Sophie D. Fosså
- Professor emerita; MD, Dr.med.
- +47 22 93 57 91
Publications 2024
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
J Natl Cancer Inst, 116 (3), 455-467
DOI 10.1093/jnci/djad236, PubMed 37966940
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer
Eur Urol Open Sci, 63, 62-70
DOI 10.1016/j.euros.2024.03.005, PubMed 38558766
Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway
Clin Genitourin Cancer, 22 (6), 102219
DOI 10.1016/j.clgc.2024.102219, PubMed 39340952
Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
Scand J Urol, 59, 121-125
DOI 10.2340/sju.v59.40070, PubMed 38888041
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE
Fertil Steril, 122 (3), 514-524
DOI 10.1016/j.fertnstert.2024.05.002, PubMed 38729340
Publications 2023
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge
BJU Int, 133 (1), 104-111
DOI 10.1111/bju.16211, PubMed 37869764
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Eur Urol, 86 (1), 20-26
DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639
A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors
Acta Obstet Gynecol Scand, 102 (2), 218-225
DOI 10.1111/aogs.14490, PubMed 36683549
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Ann Oncol, 34 (12), 1165-1174
DOI 10.1016/j.annonc.2023.09.3101, PubMed 37739265
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Eur Urol Open Sci, 53, 6-15
DOI 10.1016/j.euros.2023.04.005, PubMed 37441342
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Scand J Urol, 58, 101-108
DOI 10.2340/sju.v58.5923, PubMed 37953521
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scand J Urol, 58, 133-140
DOI 10.2340/sju.v58.14730, PubMed 38116675
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
J Clin Oncol, 41 (12), 2211-2226
DOI 10.1200/JCO.22.01456, PubMed 36626694
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
Acta Oncol, 62 (12), 1716-1722
DOI 10.1080/0284186X.2023.2257876, PubMed 37725527
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Acta Oncol, 62 (6), 657-665
DOI 10.1080/0284186X.2023.2224051, PubMed 37353983
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Int J Cancer, 153 (8), 1512-1519
DOI 10.1002/ijc.34625, PubMed 37334652
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
Scand J Urol, 58, 68-75
DOI 10.2340/sju.v58.9571, PubMed 37644904
Publications 2022
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
Ear Hear, 43 (3), 794-807
DOI 10.1097/AUD.0000000000001172, PubMed 35067571
High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
Curr Oncol, 29 (8), 5823-5832
DOI 10.3390/curroncol29080459, PubMed 36005197
A study of high neuroticism in long-term survivors of childhood, adolescence, and young adult cancers
Sci Rep, 12 (1), 12325
DOI 10.1038/s41598-022-15697-3, PubMed 35853946
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
Clin Transl Radiat Oncol, 37, 78-84
DOI 10.1016/j.ctro.2022.08.003, PubMed 36093341
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
J Clin Oncol, 40 (23), 2588-2599
DOI 10.1200/JCO.21.02105, PubMed 35380874
Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors
Acta Oncol, 61 (3), 357-362
DOI 10.1080/0284186X.2021.2006775, PubMed 35103559
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 56 (3), 214-220
DOI 10.1080/21681805.2022.2056633, PubMed 35506475
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
BMC Cancer, 22 (1), 1301
DOI 10.1186/s12885-022-10394-w, PubMed 36510166
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554
Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
Acta Oncol, 61 (5), 615-618
DOI 10.1080/0284186X.2022.2051204, PubMed 35300560
Publications 2021
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
DOI 10.1093/ehjci/jeaa289, PubMed 33152065
The use of reTURB in T1 bladder cancer: a Norwegian population-based study
Scand J Urol, 55 (4), 268-274
DOI 10.1080/21681805.2021.1917652, PubMed 33998957
A Controlled Study of Major Depressive Episodes in Long-Term Childhood, Adolescence, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225800, PubMed 34830953
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
J Clin Oncol, 39 (32), 3561-3573
DOI 10.1200/JCO.21.00637, PubMed 34388002
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594
Early detection of prostate cancer in firefighters: a register-based study of prognostic factors and survival
Occup Environ Med, 79 (3), 200-206
DOI 10.1136/oemed-2021-107622, PubMed 34510005
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829
Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
Acta Oncol, 60 (4), 426-433
DOI 10.1080/0284186X.2021.1887514, PubMed 33617403
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
Prostate Cancer Prostatic Dis, 26 (1), 53-58
DOI 10.1038/s41391-021-00445-x, PubMed 34493838
Needs for information about lifestyle and rehabilitation in long-term young adult cancer survivors
Support Care Cancer, 30 (1), 521-533
DOI 10.1007/s00520-021-06418-z, PubMed 34333716
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
Hum Reprod, 36 (6), 1561-1573
DOI 10.1093/humrep/deab035, PubMed 33744927
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
Hum Reprod, 36 (4), 1120-1133
DOI 10.1093/humrep/deaa342, PubMed 33582778
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
Cancers (Basel), 13 (18)
DOI 10.3390/cancers13184598, PubMed 34572825
Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
Eur Urol Open Sci, 26, 55-63
DOI 10.1016/j.euros.2021.01.011, PubMed 34337508
Publications 2020
In Reply to Sari et al
Int J Radiat Oncol Biol Phys, 107 (2), 388-389
DOI 10.1016/j.ijrobp.2020.02.027, PubMed 32112877
T1 bladder cancer in Norway: treatment and survival
Scand J Urol, 54 (5), 370-375
DOI 10.1080/21681805.2020.1803401, PubMed 32783590
Lifestyle among long-term survivors of cancers in young adulthood
Support Care Cancer, 29 (1), 289-300
DOI 10.1007/s00520-020-05445-6, PubMed 32358776
Long-term cervical cancer survivors on disability pension: a subgroup in need of attention from health care providers
J Cancer Surviv, 14 (4), 578-585
DOI 10.1007/s11764-020-00877-9, PubMed 32279150
Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors
J Sex Med, 17 (7), 1359-1369
DOI 10.1016/j.jsxm.2020.03.010, PubMed 32336554
A cross-sectional study of current work ability after radical prostatectomy
BMC Urol, 20 (1), 9
DOI 10.1186/s12894-020-0579-9, PubMed 32005115
The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
Int Urol Nephrol, 53 (4), 691-698
DOI 10.1007/s11255-020-02688-4, PubMed 33118115
A prospective study on cancer risk after total hip replacements for 41,402 patients linked to the Cancer registry of Norway
BMC Musculoskelet Disord, 21 (1), 599
DOI 10.1186/s12891-020-03605-7, PubMed 32900364
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Cancer Epidemiol, 67, 101744
DOI 10.1016/j.canep.2020.101744, PubMed 32652337
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165
Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma
J Plast Surg Hand Surg, 55 (2), 127-131
DOI 10.1080/2000656X.2020.1842746, PubMed 33176535
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
J Clin Oncol, 39 (4), 308-318
DOI 10.1200/JCO.20.02713, PubMed 33356420
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
JNCI Cancer Spectr, 4 (4), pkaa022
DOI 10.1093/jncics/pkaa022, PubMed 32704617
Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study)
Support Care Cancer, 29 (6), 2947-2957
DOI 10.1007/s00520-020-05790-6, PubMed 33011832
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
JNCI Cancer Spectr, 4 (3), pkaa017
DOI 10.1093/jncics/pkaa017, PubMed 32455335
Longitudinal kidney function outcome in aging testicular cancer survivors
Acta Oncol, 59 (4), 467-474
DOI 10.1080/0284186X.2020.1724328, PubMed 32043400
Causal inference in continuous time: an example on prostate cancer therapy
Biostatistics, 21 (1), 172-185
DOI 10.1093/biostatistics/kxy036, PubMed 30124773
The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up
Laryngoscope, 130 (9), E515-E521
DOI 10.1002/lary.28543, PubMed 32065408
Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study
Br J Psychiatry, 217 (2), 427-433
DOI 10.1192/bjp.2019.211, PubMed 31587671
Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
Int J Cancer, 147 (11), 3189-3198
DOI 10.1002/ijc.33151, PubMed 32525564
Prostatectomy with or without post-operative radiotherapy: long-term adverse effects and quality of life
Scand J Urol, 55 (1), 9-16
DOI 10.1080/21681805.2020.1854343, PubMed 33349097
Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study
Cancer Med, 9 (18), 6646-6657
DOI 10.1002/cam4.3297, PubMed 32750229
Publications 2019
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors
J Natl Compr Canc Netw, 17 (5), 459-468
DOI 10.6004/jnccn.2018.7109, PubMed 31085753
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
JNCI Cancer Spectr, 4 (2), pkz079
DOI 10.1093/jncics/pkz079, PubMed 32190815
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
Int J Radiat Oncol Biol Phys, 106 (4), 706-714
DOI 10.1016/j.ijrobp.2019.11.027, PubMed 31786279
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
Clin Epigenetics, 11 (1), 179
DOI 10.1186/s13148-019-0764-4, PubMed 31796056
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Acta Oncol, 58 (5), 753-762
DOI 10.1080/0284186X.2018.1557344, PubMed 30696351
Employment Status and Work Ability in Long-Term Young Adult Cancer Survivors
J Adolesc Young Adult Oncol, 8 (3), 304-311
DOI 10.1089/jayao.2018.0109, PubMed 30900929
Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
Clin Cancer Res, 25 (13), 4104-4116
DOI 10.1158/1078-0432.CCR-18-3179, PubMed 30952644
Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique
Scand J Urol, 53 (6), 385-391
DOI 10.1080/21681805.2019.1693625, PubMed 31797716
Testicular Cancer Survivorship
J Natl Compr Canc Netw, 17 (12), 1557-1568
DOI 10.6004/jnccn.2019.7369, PubMed 31805527
Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors
Acta Oncol, 58 (5), 682-689
DOI 10.1080/0284186X.2018.1562210, PubMed 30862228
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
Int J Cancer, 147 (1), 21-32
DOI 10.1002/ijc.32704, PubMed 31597192
Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study
PLoS One, 14 (12), e0225942
DOI 10.1371/journal.pone.0225942, PubMed 31851716
Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients
Prostate, 79 (16), 1852-1860
DOI 10.1002/pros.23911, PubMed 31566779
Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the NOR-CAYACS study
J Cancer Surviv, 13 (3), 353-363
DOI 10.1007/s11764-019-00757-x, PubMed 30993649
A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomy
Asian J Urol, 7 (2), 161-169
DOI 10.1016/j.ajur.2019.08.001, PubMed 32257809
Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
Clin Cancer Res, 25 (19), 5913-5924
DOI 10.1158/1078-0432.CCR-19-0113, PubMed 31296530
Publications 2018
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
Cancer Treat Rev, 66, 23-44
DOI 10.1016/j.ctrv.2018.03.005, PubMed 29673922
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
Eur J Cancer, 103, 227-237
DOI 10.1016/j.ejca.2018.08.007, PubMed 30273888
Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
Support Care Cancer, 27 (3), 1001-1011
DOI 10.1007/s00520-018-4389-5, PubMed 30094728
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
Clin Genitourin Cancer, 16 (4), e761-e769
DOI 10.1016/j.clgc.2018.01.011, PubMed 29534941
Late adverse outcomes after treatment of testicular cancer. German version
Onkologe, 24 (10), 802-808
DOI 10.1007/s00761-018-0462-4
Late adverse outcomes after treatment of testicular cancer
Onkologe, 24 2, S104-S109
DOI 10.1007/s00761-018-0442-8
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
Adv Urol, 2018, 8671832
DOI 10.1155/2018/8671832, PubMed 29670654
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
Acta Oncol, 57 (8), 1075-1083
DOI 10.1080/0284186X.2018.1433323, PubMed 29384420
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Acta Oncol, 57 (10), 1392-1400
DOI 10.1080/0284186X.2018.1473641, PubMed 29775128
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Ann Oncol, 29 (8), 1658-1686
DOI 10.1093/annonc/mdy217, PubMed 30113631
Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1213-1215
DOI 10.1007/s11136-017-1708-0, PubMed 29168123
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
J Clin Oncol, 36 (15), 1505-1512
DOI 10.1200/JCO.2017.77.0735, PubMed 29617189
Cancer Survivorship in Adults
Recent Results Cancer Res, 210, 123-143
DOI 10.1007/978-3-319-64310-6_8, PubMed 28924683
Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
Acta Obstet Gynecol Scand, 98 (2), 240-249
DOI 10.1111/aogs.13477, PubMed 30289161
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
JMIR Res Protoc, 7 (9), e10824
DOI 10.2196/10824, PubMed 30215599
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
BMC Cancer, 18 (1), 930
DOI 10.1186/s12885-018-4834-3, PubMed 30257669
Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort
Radiother Oncol, 132, 211-217
DOI 10.1016/j.radonc.2018.10.013, PubMed 30389241
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors
J Natl Compr Canc Netw, 16 (3), 257-265
DOI 10.6004/jnccn.2017.7046, PubMed 29523664
Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
World J Urol, 37 (8), 1571-1580
DOI 10.1007/s00345-018-2570-6, PubMed 30483947
Publications 2017
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
BMC Urol, 17 (1), 111
DOI 10.1186/s12894-017-0302-7, PubMed 29197360
Genetic factors influencing prostate cancer risk in Norwegian men
Prostate, 78 (3), 186-192
DOI 10.1002/pros.23453, PubMed 29181843
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
Clin Cancer Res, 23 (19), 5757-5768
DOI 10.1158/1078-0432.CCR-16-3224, PubMed 28611204
[Not Available]
Tidsskr Nor Laegeforen, 137 (4), 259-260
DOI 10.4045/tidsskr.17.0046, PubMed 28225224
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
J Clin Oncol, 35 (11), 1211-1222
DOI 10.1200/JCO.2016.70.3108, PubMed 28240972
Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
Radiat Res, 187 (2), 186-195
DOI 10.1667/RR14453.1, PubMed 28118119
Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue
Acta Oncol, 56 (2), 245-253
DOI 10.1080/0284186X.2016.1266091, PubMed 28075207
A controlled study of the influence of comorbidity on activities of daily living in elderly cancer survivors (the HUNT-3 survey)
J Geriatr Oncol, 8 (5), 328-335
DOI 10.1016/j.jgo.2017.05.007, PubMed 28629695
Useful and gentle about the Munchhaus syndrome
Tidsskr. Nor. Laegeforen., 137 (14-15), 976
Modern treatment of metastatic prostate cancer
Tidsskr Nor Laegeforen, 137 (11), 803-805
DOI 10.4045/tidsskr.16.0265, PubMed 28597635
[Not Available]
Tidsskr Nor Laegeforen, 137 (14-15)
DOI 10.4045/tidsskr.17.0579, PubMed 28828789
Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1201-1212
DOI 10.1007/s11136-017-1684-4, PubMed 28808829
Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors
J Adolesc Young Adult Oncol, 6 (3), 470-476
DOI 10.1089/jayao.2017.0018, PubMed 28837384
Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma
Support Care Cancer, 25 (8), 2445-2454
DOI 10.1007/s00520-017-3651-6, PubMed 28236146
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
Eur Urol, 73 (3), 427-435
DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
Acta Oncol, 56 (4), 590-598
DOI 10.1080/0284186X.2016.1267870, PubMed 28077016
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
Gynecol Oncol, 145 (1), 148-153
DOI 10.1016/j.ygyno.2017.02.006, PubMed 28202195
Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
BMC Res Notes, 10 (1), 214
DOI 10.1186/s13104-017-2531-y, PubMed 28619116
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer
Health Qual Life Outcomes, 15 (1), 97
DOI 10.1186/s12955-017-0670-4, PubMed 28490338
Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study
Acta Oncol, 56 (10), 1295-1301
DOI 10.1080/0284186X.2017.1314006, PubMed 28422584
Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
Urology, 110, 140-147
DOI 10.1016/j.urology.2017.07.048, PubMed 28823634
Publications 2016
Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study
Acta Oncol, 55 (12), 1400-1407
DOI 10.1080/0284186X.2016.1191666, PubMed 27332723
Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia
Am J Cardiol, 118 (3), 446-52
DOI 10.1016/j.amjcard.2016.05.021, PubMed 27296561
Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia
Eur Heart J Cardiovasc Imaging, 17 (7), 735-41
DOI 10.1093/ehjci/jew018, PubMed 26917232
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
J Cancer Surviv, 10 (5), 842-9
DOI 10.1007/s11764-016-0529-4, PubMed 26920871
Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries
Scand J Urol, 50 (5), 330-7
DOI 10.1080/21681805.2016.1201859, PubMed 27398736
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
Scand J Urol, 50 (4), 280-5
DOI 10.3109/21681805.2016.1163617, PubMed 27049891
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
Eur Urol, 70 (4), 684-691
DOI 10.1016/j.eururo.2016.03.021, PubMed 27025586
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
J Clin Oncol, 34 (23), 2712-20
DOI 10.1200/JCO.2016.66.8822, PubMed 27354478
Reply to S. Alanee et al
J Clin Oncol, 34 (11), 1285-6
DOI 10.1200/JCO.2015.65.7015, PubMed 26858338
Increased pancreatic cancer risk following radiotherapy for testicular cancer
Br J Cancer, 115 (7), 901-8
DOI 10.1038/bjc.2016.272, PubMed 27599043
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
Urol Oncol, 34 (11), 487.e13-487.e20
DOI 10.1016/j.urolonc.2016.06.012, PubMed 27523611
Health-related quality of life in teenagers with a parent with cancer
Eur J Oncol Nurs, 22, 46-53
DOI 10.1016/j.ejon.2016.03.004, PubMed 27179892
Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
J Adolesc Young Adult Oncol, 6 (1), 120-126
DOI 10.1089/jayao.2016.0041, PubMed 27841952
Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor
Cancer Epidemiol Biomarkers Prev, 25 (5), 773-9
DOI 10.1158/1055-9965.EPI-15-1153, PubMed 26908435
The effect of strength training on muscle cellular stress in prostate cancer patients on ADT
Endocr Connect, 5 (2), 74-82
DOI 10.1530/EC-15-0120, PubMed 27169606
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859
Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry
J Appl Lab Med, 1 (2), 143-151
DOI 10.1373/jalm.2016.020081, PubMed 33626787
Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
Clin Cancer Res, 23 (13), 3325-3333
DOI 10.1158/1078-0432.CCR-16-2809, PubMed 28039263
Publications 2015
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages
Neoplasia, 17 (2), 167-74
DOI 10.1016/j.neo.2014.12.005, PubMed 25748235
Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study
Radiother Oncol, 115 (3), 314-20
DOI 10.1016/j.radonc.2015.05.021, PubMed 26091575
Work ability in prostate cancer survivors after radical prostatectomy
Scand J Urol, 50 (2), 116-22
DOI 10.3109/21681805.2015.1100674, PubMed 26609896
Global Quality of Life After Curative Treatment for Prostate Cancer: What Matters? A Study Among Members of the Norwegian Prostate Cancer Patient Association
Clin Genitourin Cancer, 13 (6), 518-24
DOI 10.1016/j.clgc.2015.07.004, PubMed 26303590
Cancer patients' participation in population-based health surveys: findings from the HUNT studies
BMC Res Notes, 8, 649
DOI 10.1186/s13104-015-1635-5, PubMed 26541408
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
J Clin Oncol, 33 (28), 3105-15
DOI 10.1200/JCO.2014.60.3654, PubMed 26240226
Long-term Morbidity of Testicular Cancer Treatment
Urol Clin North Am, 42 (3), 393-408
DOI 10.1016/j.ucl.2015.05.002, PubMed 26216826
Lifestyles of cancer survivors attending an inpatient educational program-a cross-sectional study
Support Care Cancer, 24 (4), 1527-36
DOI 10.1007/s00520-015-2936-x, PubMed 26370221
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study
Anticancer Res, 35 (3), 1619-25
PubMed 25750319
Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only
Pediatr Blood Cancer, 63 (1), 133-8
DOI 10.1002/pbc.25690, PubMed 26312396
Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
Hum Mol Genet, 24 (14), 4138-46
DOI 10.1093/hmg/ddv129, PubMed 25877299
Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when
Patient Educ Couns, 98 (5), 604-11
DOI 10.1016/j.pec.2015.01.016, PubMed 25704291
"Natural course" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment
Scand J Urol, 49 (6), 440-445
DOI 10.3109/21681805.2015.1059881, PubMed 26139461
The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer
ESC Heart Fail, 2 (3), 142-149
DOI 10.1002/ehf2.12048, PubMed 28834675
Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy
Acta Oncol, 54 (10), 1805-13
DOI 10.3109/0284186X.2015.1037008, PubMed 25927504
Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy
Scand J Med Sci Sports, 26 (9), 1026-35
DOI 10.1111/sms.12543, PubMed 26282343
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
DOI 10.1007/s11764-015-0439-x, PubMed 25750158
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk Lymphoma, 56 (12), 3306-14
DOI 10.3109/10428194.2015.1036258, PubMed 25827172
Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors
Ann Oncol, 26 (10), 2133-40
DOI 10.1093/annonc/mdv328, PubMed 26265167
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients
Clin Genitourin Cancer, 14 (3), e265-73
DOI 10.1016/j.clgc.2015.10.009, PubMed 26778476
Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure - Relationship to cardiac radiation dose and cardiovascular risk factors
Radiother Oncol, 114 (3), 328-34
DOI 10.1016/j.radonc.2015.01.006, PubMed 25600105
Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7-40 years after diagnosis
Support Care Cancer, 24 (4), 1497-506
DOI 10.1007/s00520-015-2940-1, PubMed 26361760
A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy
Scand J Urol, 49 (6), 433-439
DOI 10.3109/21681805.2015.1042038, PubMed 26116048
Publications 2014
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones
Hum Reprod, 29 (12), 2844-51
DOI 10.1093/humrep/deu274, PubMed 25336703
Left ventricular function in long-term survivors of childhood lymphoma
Am J Cardiol, 114 (3), 483-90
DOI 10.1016/j.amjcard.2014.04.055, PubMed 24948492
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609
Pancreatic cancer risk after treatment of Hodgkin lymphoma
Ann Oncol, 25 (10), 2073-2079
DOI 10.1093/annonc/mdu287, PubMed 25185241
Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients
Acta Orthop, 85 (6), 652-6
DOI 10.3109/17453674.2014.963784, PubMed 25238432
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Eur J Cancer, 50 (9), 1617-27
DOI 10.1016/j.ejca.2014.03.010, PubMed 24703899
Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience REPLY
Urology, 83 (1), 153
DOI 10.1016/j.urology.2013.08.086
Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital
Res Rep Urol, 6, 121-6
DOI 10.2147/RRU.S68477, PubMed 25328865
Reply to G. Gandaglia et al
J Clin Oncol, 32 (11), 1167-9
DOI 10.1200/JCO.2013.54.6168, PubMed 24590643
A controlled cohort study of long-term income in colorectal cancer patients
Support Care Cancer, 22 (10), 2821-30
DOI 10.1007/s00520-014-2258-4, PubMed 24821364
Increased stomach cancer risk following radiotherapy for testicular cancer
Br J Cancer, 112 (1), 44-51
DOI 10.1038/bjc.2014.552, PubMed 25349972
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme
Eur J Cancer, 50 (6), 1090-9
DOI 10.1016/j.ejca.2014.01.006, PubMed 24485664
How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
J Urol, 192 (4), 1155-61
DOI 10.1016/j.juro.2014.03.113, PubMed 24727062
Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
Scand J Urol, 49 (3), 250-9
DOI 10.3109/21681805.2014.980845, PubMed 25428752
Does a parental history of cancer moderate the associations between impaired health status in parents and psychosocial problems in teenagers: a HUNT study
Cancer Med, 3 (4), 919-26
DOI 10.1002/cam4.245, PubMed 24723456
Arm and shoulder morbidity following surgery and radiotherapy for breast cancer
Acta Oncol, 53 (4), 521-9
DOI 10.3109/0284186X.2014.880512, PubMed 24495044
Cancer survivorship in adults
Recent Results Cancer Res, 197, 103-20
DOI 10.1007/978-3-642-40187-9_8, PubMed 24305772
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862
Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma
Haematologica, 99 (10), e193-6
DOI 10.3324/haematol.2014.108258, PubMed 25271315
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
Scand J Urol, 49 (3), 211-7
DOI 10.3109/21681805.2014.982169, PubMed 25515952
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Ann Oncol, 26 (5), 833-838
DOI 10.1093/annonc/mdu514, PubMed 25378299
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Lancet Oncol, 15 (7), 738-46
DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010)
Eur J Cancer, 50 (11), 1942-50
DOI 10.1016/j.ejca.2014.03.288, PubMed 24857045
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
Gynecol Oncol, 136 (2), 224-9
DOI 10.1016/j.ygyno.2014.12.010, PubMed 25511159
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Lancet Oncol, 16 (1), 76-86
DOI 10.1016/S1470-2045(14)71160-X, PubMed 25498218
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics
J Natl Cancer Inst, 106 (5)
DOI 10.1093/jnci/dju044, PubMed 24623533
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities
Eur J Cancer, 50 (11), 1957-63
DOI 10.1016/j.ejca.2014.04.018, PubMed 24820932
Publications 2013
Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor
Hum Reprod, 28 (7), 1995-2002
DOI 10.1093/humrep/det127, PubMed 23639623
Incidence and mortality of second sarcomas - a population-based study
Eur J Cancer, 49 (15), 3292-302
DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025
Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events
Scand J Urol, 47 (6), 449-55
DOI 10.3109/21681805.2013.780257, PubMed 24328733
Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - a systematic review
Radiother Oncol, 110 (1), 55-60
DOI 10.1016/j.radonc.2013.08.008, PubMed 24044801
Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review
Acta Oncol, 53 (2), 164-73
DOI 10.3109/0284186X.2013.837582, PubMed 24195692
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Nat Genet, 45 (6), 680-5
DOI 10.1038/ng.2634, PubMed 23666239
Return to work and sick leave after radical prostatectomy: a prospective clinical study
Acta Oncol, 53 (6), 744-51
DOI 10.3109/0284186X.2013.844357, PubMed 24195691
SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling
Int J Radiat Oncol Biol Phys, 86 (4), 791-9
DOI 10.1016/j.ijrobp.2013.02.025, PubMed 23597419
Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience
Urology, 83 (1), 146-52
DOI 10.1016/j.urology.2013.08.081, PubMed 24238563
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study
J Clin Oncol, 31 (30), 3807-14
DOI 10.1200/JCO.2013.50.3409, PubMed 24043737
Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease
Eur Urol, 65 (3), 635-41
DOI 10.1016/j.eururo.2013.01.007, PubMed 23351721
Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
Eur Urol, 64 (1), e11-2
DOI 10.1016/j.eururo.2013.03.045, PubMed 23602404
High Prevalence of Chronic Fatigue in Adult Long-Term Survivors of Acute Lymphoblastic Leukemia and Lymphoma During Childhood and Adolescence
J. Adolesc. Young Adult Oncol., 2 (1), 2-9
DOI 10.1089/jayao.2012.0015
Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma
Brain Behav Immun, 30, 80-7
DOI 10.1016/j.bbi.2013.01.006, PubMed 23333795
A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors
Acta Oncol, 53 (6), 735-43
DOI 10.3109/0284186X.2013.844354, PubMed 24345277
Study of generic quality of life in patients operated on for post-prostatectomy incontinence
Int J Urol, 20 (9), 889-95
DOI 10.1111/iju.12077, PubMed 23418855
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
Br J Cancer, 110 (1), 256-63
DOI 10.1038/bjc.2013.551, PubMed 24263066
Psychosocial problems of teenagers who have a parent with cancer: a population-based case-control study (young-HUNT study)
J Clin Oncol, 31 (32), 4099-104
DOI 10.1200/JCO.2013.50.7061, PubMed 24101041
Dose Distribution in the Heart and Cardiac Chambers Following 4-field Radiation Therapy of Breast Cancer: a Retrospective Study
Breast Cancer (Auckl), 7, 41-9
DOI 10.4137/BCBCR.S11118, PubMed 23589693
Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma
Pediatr Blood Cancer, 60 (5), 849-55
DOI 10.1002/pbc.24375, PubMed 23335116
Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
Hum Mol Genet, 22 (16), 3373-80
DOI 10.1093/hmg/ddt188, PubMed 23640991
Stomach cancer risk after treatment for hodgkin lymphoma
J Clin Oncol, 31 (27), 3369-77
DOI 10.1200/JCO.2013.50.6832, PubMed 23980092
Testicular cancer in 2013: towards personalized medicine--are we there yet?
Nat Rev Urol, 11 (2), 68-9
DOI 10.1038/nrurol.2013.298, PubMed 24366345
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol, 24 Suppl 6, vi125-32
DOI 10.1093/annonc/mdt304, PubMed 24078656
Alpha emitter radium-223 and survival in metastatic prostate cancer
N Engl J Med, 369 (3), 213-23
DOI 10.1056/NEJMoa1213755, PubMed 23863050
Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?
Cancer, 119 Suppl 11 (0 11), 2094-108
DOI 10.1002/cncr.28060, PubMed 23695922
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Hum Mol Genet, 22 (13), 2748-53
DOI 10.1093/hmg/ddt109, PubMed 23462292
Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009)
Gynecol Oncol, 131 (2), 330-5
DOI 10.1016/j.ygyno.2013.08.028, PubMed 24001518
Birth outcomes among offspring of adult cancer survivors: a population-based study
Int J Cancer, 133 (11), 2696-705
DOI 10.1002/ijc.28292, PubMed 23729011
Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer
Int J Radiat Oncol Biol Phys, 87 (2), 337-43
DOI 10.1016/j.ijrobp.2013.05.038, PubMed 23886416
Atherosclerotic lesions in lymphoma survivors treated with radiotherapy
Radiother Oncol, 110 (3), 448-54
DOI 10.1016/j.radonc.2013.10.029, PubMed 24231235
Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling?
Scand J Urol, 48 (2), 123-30
DOI 10.3109/21681805.2013.817483, PubMed 23885810
Publications 2012
Barriers to the implementation of surveillance for stage I testicular seminoma
Int J Radiat Oncol Biol Phys, 84 (2), 383-9
DOI 10.1016/j.ijrobp.2011.11.064, PubMed 22349043
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Ann Oncol, 24 (4), 878-88
DOI 10.1093/annonc/mds579, PubMed 23152360
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer
J Clin Oncol, 30 (32), 4004-10
DOI 10.1200/JCO.2011.40.8914, PubMed 23071246
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336
Proportion cured models applied to 23 cancer sites in Norway
Int J Cancer, 132 (7), 1700-10
DOI 10.1002/ijc.27802, PubMed 22927104
Contemporary management of postchemotherapy testis cancer
Eur Urol, 62 (5), 867-76
DOI 10.1016/j.eururo.2012.08.014, PubMed 22938868
Second malignant neoplasms in testicular cancer survivors
J Natl Compr Canc Netw, 10 (4), 545-56
DOI 10.6004/jnccn.2012.0052, PubMed 22491051
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
Prostate, 73 (3), 250-60
DOI 10.1002/pros.22564, PubMed 22821802
A cohort study of permanently reduced work ability in breast cancer patients
J Cancer Surviv, 6 (3), 345-56
DOI 10.1007/s11764-012-0215-0, PubMed 22457217
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
J Clin Oncol, 30 (30), 3752-63
DOI 10.1200/JCO.2012.43.4431, PubMed 23008318
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Hum Reprod, 27 (5), 1525-35
DOI 10.1093/humrep/des075, PubMed 22402210
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men
Int J Androl, 35 (6), 819-827
DOI 10.1111/j.1365-2605.2012.01297.x, PubMed 22882535
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer
BJU Int, 111 (2), 221-32
DOI 10.1111/j.1464-410X.2012.11198.x, PubMed 22672151
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
Eur J Cancer, 48 (16), 2993-3000
DOI 10.1016/j.ejca.2012.05.014, PubMed 22677260
Risk of treatment-related esophageal cancer among breast cancer survivors
Ann Oncol, 23 (12), 3081-3091
DOI 10.1093/annonc/mds144, PubMed 22745217
Patient knowledge of late effects of acute lymphoblastic leukaemia
Tidsskr Nor Laegeforen, 132 (18), 2052-5
DOI 10.4045/tidsskr.12.0153, PubMed 23038194
Is 'Seeking God's Help' Associated with Life Satisfaction and Disease-specific Quality of Life in Cancer Patients? The HUNT Study
Arch. Psychol. Relig., 34 (2), 191-213
DOI 10.1163/15736121-12341237
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412
A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design
BMC Cancer, 12, 123
DOI 10.1186/1471-2407-12-123, PubMed 22458865
Change in employment status of 5-year cancer survivors
Eur J Public Health, 23 (1), 116-22
DOI 10.1093/eurpub/ckr192, PubMed 22227027
Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study
J Cancer Surviv, 6 (3), 315-23
DOI 10.1007/s11764-012-0228-8, PubMed 22706884
Publications 2011
Sequelae of treatment in long-term survivors of testis cancer
Eur Urol, 60 (3), 516-26
DOI 10.1016/j.eururo.2011.05.055, PubMed 21684072
Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007)
Int J Cancer, 129 (12), 2867-74
DOI 10.1002/ijc.25943, PubMed 21626506
Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
Br J Cancer, 106 (2), 297-306
DOI 10.1038/bjc.2011.559, PubMed 22173669
Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
BMC Res Notes, 4, 252
DOI 10.1186/1756-0500-4-252, PubMed 21777440
"The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors
Qual Life Res, 21 (8), 1459-70
DOI 10.1007/s11136-011-0053-y, PubMed 22045155
Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations
Sleep Med, 12 (6), 584-90
DOI 10.1016/j.sleep.2011.01.011, PubMed 21645872
Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients
J Clin Oncol, 29 (8), 963-70
DOI 10.1200/JCO.2010.32.3204, PubMed 21300926
[Childhood cancer and fertility]
Tidsskr Nor Laegeforen, 131 (15), 1412
DOI 10.4045/tidsskr.11.0778, PubMed 21844933
Interest and preferences for exercise counselling and programming among Norwegian cancer survivors
Eur J Cancer Care (Engl), 20 (1), 96-105
DOI 10.1111/j.1365-2354.2009.01161.x, PubMed 20345456
Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients
J Cancer Educ, 26 (4), 754-60
DOI 10.1007/s13187-011-0245-8, PubMed 21626449
Morbidity, life style and psychosocial situation in cancer survivors aged 60-69 years: results from the Nord-Trøndelag health study (the HUNT-II study)
BMC Cancer, 11, 34
DOI 10.1186/1471-2407-11-34, PubMed 21266091
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study
Pediatr Blood Cancer, 59 (2), 271-7
DOI 10.1002/pbc.23363, PubMed 22021108
Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
Acta Oncol, 50 (5), 653-9
DOI 10.3109/0284186X.2010.550934, PubMed 21261507
Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study
Radiat Oncol, 6, 68
DOI 10.1186/1748-717X-6-68, PubMed 21651829
CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility
Int J Androl, 34 (1), 77-83
DOI 10.1111/j.1365-2605.2010.01057.x, PubMed 20345875
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up
J Natl Cancer Inst, 103 (3), 241-9
DOI 10.1093/jnci/djq525, PubMed 21212385
Late relapse of germ cell tumors
Hematol Oncol Clin North Am, 25 (3), 615-26, x
DOI 10.1016/j.hoc.2011.03.006, PubMed 21570613
Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
J Psychosom Res, 71 (3), 136-41
DOI 10.1016/j.jpsychores.2011.04.003, PubMed 21843747
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
Brain Behav Immun, 25 (7), 1376-83
DOI 10.1016/j.bbi.2011.04.001, PubMed 21496483
Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
J Psychosom Res, 70 (5), 403-10
DOI 10.1016/j.jpsychores.2010.12.004, PubMed 21511070
A prospective study of cognitive complaints in patients with testicular cancer
Clin Genitourin Cancer, 9 (1), 6-13
DOI 10.1016/j.clgc.2011.04.002, PubMed 21729683
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
J Clin Oncol, 30 (3), 300-7
DOI 10.1200/JCO.2011.37.4025, PubMed 22184390
Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
BJU Int, 109 (9), 1366-74
DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333
Pregnancy after adolescent and adult cancer: a population-based matched cohort study
Int J Cancer, 129 (5), 1225-36
DOI 10.1002/ijc.26045, PubMed 21387311
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
Prostate, 72 (6), 668-76
DOI 10.1002/pros.21470, PubMed 21809351
Cancer patients' needs for rehabilitation services
Acta Oncol, 50 (2), 212-22
DOI 10.3109/0284186X.2010.531050, PubMed 21231783
Social support at work and work changes among cancer survivors in Norway
Scand J Public Health, 39 (6 Suppl), 33-42
DOI 10.1177/1403494810395827, PubMed 21382846
Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy
Am J Cardiol, 107 (3), 472-7
DOI 10.1016/j.amjcard.2010.09.048, PubMed 21257017
A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
J Cancer Surviv, 5 (2), 208-16
DOI 10.1007/s11764-011-0172-z, PubMed 21259075
Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
Urology, 78 (4 Suppl), S435-43
DOI 10.1016/j.urology.2011.02.031, PubMed 21986223
Radiotherapy or surgery for spine metastases?
Acta Orthop, 82 (3), 365-71
DOI 10.3109/17453674.2011.566142, PubMed 21434789
Publications 2010
Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals
BJU Int, 107 (7), 1080-7
DOI 10.1111/j.1464-410X.2010.09649.x, PubMed 20825398
Sexual function in females after radiotherapy for rectal cancer
Acta Oncol, 49 (6), 826-32
DOI 10.3109/0284186X.2010.486411, PubMed 20615170
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
Eur Urol, 58 (1), 134-40
DOI 10.1016/j.eururo.2010.03.041, PubMed 20395037
A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors
J Cancer Surviv, 4 (3), 256-65
DOI 10.1007/s11764-010-0133-y, PubMed 20574815
A study of body image in long-term breast cancer survivors
Cancer, 116 (15), 3549-57
DOI 10.1002/cncr.25251, PubMed 20564138
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
Mol Cancer, 9, 113
DOI 10.1186/1476-4598-9-113, PubMed 20482849
Exercise behavior in cancer survivors and associated factors
J Cancer Surviv, 5 (1), 35-43
DOI 10.1007/s11764-010-0148-4, PubMed 20890674
Activity of daily living problems in older cancer survivors: a population-based controlled study
Health Soc Care Community, 18 (4), 396-406
DOI 10.1111/j.1365-2524.2010.00912.x, PubMed 20491969
Insomnia in elderly cancer survivors--a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trøndelag County (HUNT-2). Insomnia in elderly cancer survivors
Support Care Cancer, 19 (9), 1319-26
DOI 10.1007/s00520-010-0948-0, PubMed 20632038
Short-term and long-term elderly cancer survivors: a population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle
Eur J Oncol Nurs, 15 (3), 213-20
DOI 10.1016/j.ejon.2010.06.011, PubMed 20674499
Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study
Support Care Cancer, 19 (3), 323-31
DOI 10.1007/s00520-010-0820-2, PubMed 20135150
A comparative study of cancer patients with short and long sick-leave after primary treatment
Acta Oncol, 50 (3), 381-9
DOI 10.3109/0284186X.2010.500298, PubMed 20843177
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830
Mortality is persistently increased in Hodgkin's lymphoma survivors
Eur J Cancer, 46 (9), 1632-9
DOI 10.1016/j.ejca.2010.02.010, PubMed 20219350
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
Cancer Epidemiol, 34 (4), 359-67
DOI 10.1016/j.canep.2010.04.017, PubMed 20627840
Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
Prostate Cancer Prostatic Dis, 13 (2), 144-50
DOI 10.1038/pcan.2009.61, PubMed 20101260
Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs
Prostate, 70 (13), 1480-9
DOI 10.1002/pros.21183, PubMed 20687221
Blood gene expression profiling of breast cancer survivors experiencing fibrosis
Int J Radiat Oncol Biol Phys, 79 (3), 875-83
DOI 10.1016/j.ijrobp.2010.09.052, PubMed 21129856
The genetics and epigenetics of fatigue
PM R, 2 (5), 456-65
DOI 10.1016/j.pmrj.2010.04.003, PubMed 20656628
Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life
Acta Oncol, 49 (3), 347-53
DOI 10.3109/02841860903302905, PubMed 19842790
The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study
J Cancer Surviv, 5 (1), 62-72
DOI 10.1007/s11764-010-0156-4, PubMed 20972640
Predictors and course of chronic fatigue in long-term breast cancer survivors
J Cancer Surviv, 4 (4), 405-14
DOI 10.1007/s11764-010-0145-7, PubMed 20862614
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733
A study of coping in long-term testicular cancer survivors
Psychol Health Med, 15 (2), 146-58
DOI 10.1080/13548501003623955, PubMed 20391232
A prospective study of neuropsychological functioning in testicular cancer patients
Ann Oncol, 22 (5), 1062-1070
DOI 10.1093/annonc/mdq553, PubMed 21048038
Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?
Psychooncology, 20 (4), 369-77
DOI 10.1002/pon.1737, PubMed 20878832
Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
J Urol, 184 (2), 525-31
DOI 10.1016/j.juro.2010.04.009, PubMed 20620412
Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
Acta Oncol, 50 (3), 408-14
DOI 10.3109/0284186X.2010.492236, PubMed 20586661
Testicular cancer survivorship: research strategies and recommendations
J Natl Cancer Inst, 102 (15), 1114-30
DOI 10.1093/jnci/djq216, PubMed 20585105
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
Eur J Cancer, 46 (18), 3425-33
DOI 10.1016/j.ejca.2010.08.004, PubMed 20832295
Pain after palliative radiotherapy for spine metastases
Clin Oncol (R Coll Radiol), 22 (10), 828-36
DOI 10.1016/j.clon.2010.03.008, PubMed 20363110
Publications 2009
Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study
Pediatr Blood Cancer, 53 (1), 84-9
DOI 10.1002/pbc.22027, PubMed 19343771
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma
Am J Cardiol, 105 (2), 149-52
DOI 10.1016/j.amjcard.2009.09.005, PubMed 20102909
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
Prostate Cancer Prostatic Dis, 12 (3), 269-76
DOI 10.1038/pcan.2009.8, PubMed 19290019
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
DOI 10.3109/00365510903380886, PubMed 19929279
Sexual function in males after radiotherapy for rectal cancer
Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
DOI 10.1016/j.ijrobp.2009.03.075, PubMed 19880263
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
J Natl Cancer Inst, 101 (24), 1682-95
DOI 10.1093/jnci/djp413, PubMed 19940282
Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma? Reply
J. Clin. Oncol., 27 (18), 3066-3067
DOI 10.1200/JCO.2009.22.5706
Reproduction Rates After Cytotoxic Therapy Reply
J. Clin. Oncol., 27 (27), E120
DOI 10.1200/JCO.2009.23.5895
Long-term risk of receiving a total hip replacement in cancer patients
Cancer Epidemiol, 33 (3-4), 235-41
DOI 10.1016/j.canep.2009.06.009, PubMed 19744907
[Incorrect about hormone treatment in prostatic cancer]
Tidsskr Nor Laegeforen, 129 (5), 429
DOI 10.4045/tidsskr.08.0649, PubMed 19247406
Kreftoverlevere: ny kunnskap og nye muligheter i et langtidsperspektiv
Gyldendal akademisk, Oslo, 247 s.
BIBSYS 091809436, ISBN 978-82-05-39204-5
Short- and long-term morbidity after treatment for testicular cancer
BJU Int, 104 (9 Pt B), 1418-22
DOI 10.1111/j.1464-410X.2009.08869.x, PubMed 19840023
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
Lancet Oncol, 10 (4), 370-80
DOI 10.1016/S1470-2045(09)70027-0, PubMed 19286422
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
Acta Oncol, 48 (6), 842-9
DOI 10.1080/02841860902795232, PubMed 19412812
Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?
J Cancer Surviv, 3 (2), 109-16
DOI 10.1007/s11764-009-0081-6, PubMed 19241174
Received and needed social support at the workplace in Norwegian and Finnish stage 1 breast cancer survivors: a study from the Nordic Study Group of Cancer and Work (NOCWO)
Acta Oncol, 48 (1), 67-75
DOI 10.1080/02841860802314704, PubMed 18759139
Pulmonary function in long-term survivors of testicular cancer
J Clin Oncol, 27 (17), 2779-86
DOI 10.1200/JCO.2008.18.5181, PubMed 19414680
Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry
BJU Int, 105 (6), 805-11; discussion 811
DOI 10.1111/j.1464-410X.2009.08834.x, PubMed 19735258
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
Br J Cancer, 100 (3), 455-63
DOI 10.1038/sj.bjc.6604892, PubMed 19156143
Do male lymphoma survivors have impaired sexual function?
J Clin Oncol, 27 (35), 6019-26
DOI 10.1200/JCO.2009.23.2280, PubMed 19858388
Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology
Pharmacogenet Genomics, 19 (10), 751-9
DOI 10.1097/FPC.0b013e3283304253, PubMed 19741569
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
Pharmacogenomics J, 9 (5), 333-40
DOI 10.1038/tpj.2009.27, PubMed 19546881
Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors
BMC Cancer, 9, 2
DOI 10.1186/1471-2407-9-2, PubMed 19121203
Younger age-at-diagnosis for familial malignant testicular germ cell tumor
Fam Cancer, 8 (4), 451-6
DOI 10.1007/s10689-009-9264-6, PubMed 19609727
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
Urol Oncol, 28 (5), 492-9
DOI 10.1016/j.urolonc.2008.10.004, PubMed 19162511
Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer
Int J Gynecol Cancer, 19 (6), 1029-36
DOI 10.1111/IGC.0b013e3181a83cd5, PubMed 19820364
[Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders]
Urologe A, 48 (4), 372-6
DOI 10.1007/s00120-009-1945-0, PubMed 19234684
Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations
Acta Oncol, 48 (6), 804-6
DOI 10.1080/02841860902984729, PubMed 19484592
Late relapse of nonseminomatous germ cell tumours
BJU Int, 104 (9 Pt B), 1413-7
DOI 10.1111/j.1464-410X.2009.08868.x, PubMed 19840022
Late relapse of germ cell tumors
World J Urol, 27 (4), 493-500
DOI 10.1007/s00345-009-0411-3, PubMed 19373473
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Brain Behav Immun, 23 (6), 868-74
DOI 10.1016/j.bbi.2009.04.003, PubMed 19362138
Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity
Int J Radiat Oncol Biol Phys, 77 (3), 793-804
DOI 10.1016/j.ijrobp.2009.05.057, PubMed 19879063
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332
Fear of recurrence in long-term testicular cancer survivors
Psychooncology, 18 (6), 580-8
DOI 10.1002/pon.1437, PubMed 18855944
Cancer During Pregnancy: The Time Has Come for a Prospective Program Reply
J. Clin. Oncol., 27 (13), 2299
DOI 10.1200/JCO.2009.21.8255
Cutaneous Melanoma During Pregnancy: Is the Controversy Over? Reply
J. Clin. Oncol., 27 (19), E13-E14
DOI 10.1200/JCO.2009.22.3594
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Br J Cancer, 101 (4), 575-81
DOI 10.1038/sj.bjc.6605191, PubMed 19623176
A population-based study of spinal metastatic disease in South-East Norway
Clin Oncol (R Coll Radiol), 21 (10), 753-9
DOI 10.1016/j.clon.2009.09.023, PubMed 19850454
Publications 2008
OECI Workshop on late side-effects of cancer treatments
Eur J Cancer, 45 (3), 354-9
DOI 10.1016/j.ejca.2008.10.005, PubMed 19081244
Is cancer survivorship associated with reduced work engagement? A NOCWO Study
J Cancer Surviv, 2 (3), 159-68
DOI 10.1007/s11764-008-0059-9, PubMed 18654861
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
Prostate, 68 (15), 1607-14
DOI 10.1002/pros.20826, PubMed 18655095
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
Acta Oncol, 47 (8), 1475-82
DOI 10.1080/02841860802047387, PubMed 18607853
Re: Second cancers among 104760 survivors of cervical cancer: Evaluation of long-term risk - Reply
J. Natl. Cancer Inst., 100 (8), 600-601
DOI 10.1093/jnci/djn086
Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
J Clin Oncol, 27 (6), 967-73
DOI 10.1200/JCO.2008.18.4549, PubMed 19114696
Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
J Clin Oncol, 27 (3), 334-43
DOI 10.1200/JCO.2007.15.3130, PubMed 19075285
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
Eur Urol, 54 (5), 1089-94
DOI 10.1016/j.eururo.2008.01.082, PubMed 18276061
A randomized phase II trial comparing weekly taxotere plus prednisolone versus prednisolone alone in androgen-independent prostate cancer
Front Radiat Ther Oncol, 41, 108-116
DOI 10.1159/000139885, PubMed 18544992
Fertility and sexuality in young cancer survivors who have adult-onset malignancies
Hematol Oncol Clin North Am, 22 (2), 291-303, vii
DOI 10.1016/j.hoc.2008.01.002, PubMed 18395151
[Rehabilitation after cancer]
Tidsskr Nor Laegeforen, 128 (22), 2615-6
PubMed 19023358
[Courses for cancer patients--15 years' experience at The Montebello Centre in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2554-7
PubMed 19023349
Long-term survivorship after cancer: how far have we come?
Ann Oncol, 19 Suppl 5, v25-9
DOI 10.1093/annonc/mdn305, PubMed 18611895
A study of work changes due to cancer in tumor-free primary-treated cancer patients. A NOCWO study
Support Care Cancer, 16 (10), 1163-71
DOI 10.1007/s00520-008-0407-3, PubMed 18256856
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
J Cancer Surviv, 2 (3), 128-37
DOI 10.1007/s11764-008-0054-1, PubMed 18792787
High prostate cancer mortality in Norway evaluated by automated classification of medical entities
Eur J Cancer Prev, 17 (4), 331-5
DOI 10.1097/CEJ.0b013e3282f5220d, PubMed 18562957
Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
Ann Epidemiol, 18 (5), 416-21
DOI 10.1016/j.annepidem.2008.01.003, PubMed 18433667
Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature
Acta Oncol, 47 (3), 466-9
DOI 10.1080/02841860701636272, PubMed 18348004
[Gonadal function after cancer treatment in adult men]
Tidsskr Nor Laegeforen, 128 (4), 461-5
PubMed 18274582
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
BJU Int, 103 (12), 1647-54
DOI 10.1111/j.1464-410X.2008.08255.x, PubMed 19154461
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors
Genes Chromosomes Cancer, 47 (3), 247-52
DOI 10.1002/gcc.20526, PubMed 18069663
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy
Acta Oncol, 47 (5), 835-42
DOI 10.1080/02841860801961257, PubMed 18568481
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors
Breast Cancer Res Treat, 117 (2), 281-8
DOI 10.1007/s10549-008-0288-7, PubMed 19112616
Genetic variants associated with cisplatin-induced ototoxicity
Pharmacogenomics, 9 (10), 1521-30
DOI 10.2217/14622416.9.10.1521, PubMed 18855538
[Testicular cancer]
Tidsskr Nor Laegeforen, 128 (4), 457-60
PubMed 18274581
Chronic cancer-related fatigue in long-term survivors of testicular cancer
J Psychosom Res, 64 (4), 363-71
DOI 10.1016/j.jpsychores.2008.01.002, PubMed 18374735
Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)
Eur Urol, 55 (1), 14-22
DOI 10.1016/j.eururo.2008.09.008, PubMed 18823693
Fertility issues in patients with prostate cancer
BJU Int, 102 (7), 793-5
DOI 10.1111/j.1464-410X.2008.07739.x, PubMed 18489529
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study
J Clin Oncol, 27 (1), 45-51
DOI 10.1200/JCO.2008.17.4110, PubMed 19029418
A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants
Support Care Cancer, 16 (9), 987-97
DOI 10.1007/s00520-008-0411-7, PubMed 18274783
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer
Eur J Cancer, 44 (16), 2418-24
DOI 10.1016/j.ejca.2008.07.030, PubMed 18774706
Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
Int J Radiat Oncol Biol Phys, 71 (5), 1335-42
DOI 10.1016/j.ijrobp.2007.12.030, PubMed 18355976
Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy
Int J Radiat Oncol Biol Phys, 73 (4), 1141-7
DOI 10.1016/j.ijrobp.2008.05.064, PubMed 18760883
Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
Acta Oncol, 47 (2), 248-54
DOI 10.1080/02841860701630267, PubMed 18210300
Late regional density changes of the lung after radiotherapy for breast cancer
Radiother Oncol, 90 (1), 148-52
DOI 10.1016/j.radonc.2007.12.031, PubMed 18262670
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Lancet, 373 (9660), 301-8
DOI 10.1016/S0140-6736(08)61815-2, PubMed 19091394
Publications 2007
Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
Support Care Cancer, 15 (9), 1087-96
DOI 10.1007/s00520-007-0227-x, PubMed 17347843
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
Int J Cancer, 120 (8), 1603-9
DOI 10.1002/ijc.22488, PubMed 17230512
10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
Breast Cancer Res Treat, 106 (3), 439-51
DOI 10.1007/s10549-007-9509-8, PubMed 17277968
Gonadal dysfunction and fertility problems in cancer survivors
Acta Oncol, 46 (4), 480-9
DOI 10.1080/02841860601166958, PubMed 17497315
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
J Natl Cancer Inst, 99 (21), 1634-43
DOI 10.1093/jnci/djm201, PubMed 17971527
Is the sexual function compromised in long-term testicular cancer survivors?
Eur Urol, 52 (5), 1438-47
DOI 10.1016/j.eururo.2007.02.046, PubMed 17350159
Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy
Int J Radiat Oncol Biol Phys, 67 (4), 1163-71
DOI 10.1016/j.ijrobp.2006.11.009, PubMed 17336217
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
Radiat Oncol, 2, 25
DOI 10.1186/1748-717X-2-25, PubMed 17623063
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
Ann Oncol, 19 (2), 259-64
DOI 10.1093/annonc/mdm472, PubMed 18042838
Noncancer causes of death in survivors of testicular cancer
J Natl Cancer Inst, 99 (7), 533-44
DOI 10.1093/jnci/djk111, PubMed 17405998
Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis
Acta Oncol, 46 (4), 452-61
DOI 10.1080/02841860601182641, PubMed 17497312
Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
Eur Urol, 52 (6), 1691-8
DOI 10.1016/j.eururo.2007.01.104, PubMed 17306441
Long term physical sequelae after adult-onset cancer
J Cancer Surviv, 2 (1), 3-11
DOI 10.1007/s11764-007-0039-5, PubMed 18648982
The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study
Support Care Cancer, 15 (11), 1309-1318
DOI 10.1007/s00520-007-0251-x, PubMed 17450387
A controlled study of job strain in primary-treated cancer patients without metastases
Acta Oncol, 46 (4), 534-44
DOI 10.1080/02841860601156132, PubMed 17497321
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
J Clin Oncol, 25 (12), 1489-97
DOI 10.1200/JCO.2006.09.0936, PubMed 17372278
Leukemia following breast cancer: an international population-based study of 376,825 women
Breast Cancer Res Treat, 105 (3), 359-68
DOI 10.1007/s10549-006-9460-0, PubMed 17221155
Post-treatment parenthood in Hodgkin's lymphoma survivors
Br J Cancer, 96 (9), 1442-9
DOI 10.1038/sj.bjc.6603711, PubMed 17406362
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Eur Urol, 53 (3), 497-513
DOI 10.1016/j.eururo.2007.12.025, PubMed 18191015
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Eur Urol, 53 (3), 478-96
DOI 10.1016/j.eururo.2007.12.024, PubMed 18191324
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
Gynecol Oncol, 108 (2), 348-54
DOI 10.1016/j.ygyno.2007.10.009, PubMed 17996925
Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
J Clin Oncol, 25 (15), 2049-56
DOI 10.1200/JCO.2006.09.1769, PubMed 17513809
Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood
Hum Reprod, 23 (1), 178-86
DOI 10.1093/humrep/dem362, PubMed 18024486
Follow-up of long-term cancer survivors in the Nordic countries
Acta Oncol, 46 (4), 433-40
DOI 10.1080/02841860701203552, PubMed 17497309
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study
J Transl Med, 5, 70
DOI 10.1186/1479-5876-5-70, PubMed 18162130
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors
J Clin Oncol, 25 (6), 708-14
DOI 10.1200/JCO.2006.08.9599, PubMed 17228018
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study
BMC Cancer, 7, 210
DOI 10.1186/1471-2407-7-210, PubMed 17997822
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
Histol Histopathol, 22 (4), 349-63
DOI 10.14670/HH-22.349, PubMed 17290345
Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers
J Natl Cancer Inst, 99 (16), 1248-56
DOI 10.1093/jnci/djm081, PubMed 17686826
[Women's academic careers in medicine]
Tidsskr Nor Laegeforen, 127 (16), 2109-12
PubMed 17717577
Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients
J Clin Oncol, 25 (10), 1301-2
DOI 10.1200/JCO.2007.10.6682, PubMed 17401029
Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy
BJOG, 114 (9), 1150-8
DOI 10.1111/j.1471-0528.2007.01445.x, PubMed 17655733
The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample
J Womens Health (Larchmt), 16 (1), 139-48
DOI 10.1089/jwh.2006.0052, PubMed 17324105
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
J Cancer Surviv, 1 (1), 8-16
DOI 10.1007/s11764-007-0012-3, PubMed 18648940
Publications 2006
Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma
Acta Oncol, 45 (2), 226-8
DOI 10.1080/02841860500400995, PubMed 16546876
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci
Hum Mol Genet, 15 (3), 443-51
DOI 10.1093/hmg/ddi459, PubMed 16407372
Long-term outcome after adult-onset cancer
Ann Oncol, 17 Suppl 10, x293-8
DOI 10.1093/annonc/mdl276, PubMed 17018741
Prostatakreft: til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 42 s.
BIBSYS 06036579x
Global quality of life in primary caregivers of patients with cancer in palliative phase staying at home
Support Care Cancer, 14 (9), 943-51
DOI 10.1007/s00520-006-0026-9, PubMed 16523266
Primary caregivers of cancer patients in the palliative phase: a path analysis of variables influencing their burden
Soc Sci Med, 63 (9), 2429-39
DOI 10.1016/j.socscimed.2006.06.008, PubMed 16887247
The caregiver reaction assessment: psychometrics, and temporal stability in primary caregivers of Norwegian cancer patients in late palliative phase
Psychooncology, 15 (6), 517-27
DOI 10.1002/pon.987, PubMed 16189843
A comparative study of living conditions in cancer patients who have returned to work after curative treatment
Support Care Cancer, 14 (10), 1020-9
DOI 10.1007/s00520-006-0042-9, PubMed 16572315
Components of the metabolic syndrome in long-term survivors of testicular cancer
Ann Oncol, 18 (2), 241-8
DOI 10.1093/annonc/mdl372, PubMed 17060482
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
Ann Oncol, 17 (9), 1428-33
DOI 10.1093/annonc/mdl149, PubMed 16831852
[Malignant melanoma--diagnosis and treatment]
Tidsskr Nor Laegeforen, 126 (23), 3094-7
PubMed 17160112
[Curative treatment of prostatic cancer in Norway in 1998 and 2001]
Tidsskr Nor Laegeforen, 126 (7), 912-6
PubMed 16554883
[Treatment of hormone-resistant prostate cancer]
Tidsskr Nor Laegeforen, 126 (21), 2798-801
PubMed 17086220
The effects of cancer and cancer treatments on male reproductive function
Nat Clin Pract Urol, 3 (6), 312-22
DOI 10.1038/ncpuro0508, PubMed 16763643
Assessment of male sexual function by the Brief Sexual Function Inventory
BJU Int, 97 (2), 316-23
DOI 10.1111/j.1464-410X.2005.05904.x, PubMed 16430637
Late recurrences of germ cell malignancies: a population-based experience over three decades
Br J Cancer, 94 (6), 820-7
DOI 10.1038/sj.bjc.6603014, PubMed 16508636
Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors
Qual Life Res, 15 (5), 791-800
DOI 10.1007/s11136-005-5370-6, PubMed 16721639
Late relapses of germ cell malignancies: incidence, management, and prognosis
J Clin Oncol, 24 (35), 5503-11
DOI 10.1200/JCO.2006.08.1836, PubMed 17158535
Suicide after breast cancer: an international population-based study of 723,810 women
J Natl Cancer Inst, 98 (19), 1416-9
DOI 10.1093/jnci/djj377, PubMed 17018788
Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
J Natl Cancer Inst, 98 (3), 215-8
DOI 10.1093/jnci/djj017, PubMed 16449681
Management satisfaction in survivors of testicular cancer
Anticancer Res, 26 (2B), 1463-9
PubMed 16619559
Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy
J Sports Med Phys Fitness, 46 (1), 122-7
PubMed 16596110
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients
Eur Urol, 51 (2), 424-32
DOI 10.1016/j.eururo.2006.06.047, PubMed 16911854
A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer
Gynecol Oncol, 102 (3), 563-72
DOI 10.1016/j.ygyno.2006.03.050, PubMed 16716379
Publications 2005
Paternity following treatment for testicular cancer
J Natl Cancer Inst, 97 (21), 1580-8
DOI 10.1093/jnci/dji339, PubMed 16264178
Study of anxiety disorder and depression in long-term survivors of testicular cancer
J Clin Oncol, 23 (10), 2389-95
DOI 10.1200/JCO.2005.05.061, PubMed 15800331
Quality of life in survivors of testicular cancer
Urol Oncol, 23 (3), 193-200
DOI 10.1016/j.urolonc.2005.03.004, PubMed 15907721
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
Br J Cancer, 92 (12), 2107-13
DOI 10.1038/sj.bjc.6602624, PubMed 15928672
[Are all LH-RH analogues equally effective in prostate cancer?]
Tidsskr Nor Laegeforen, 125 (18), 2493-5
PubMed 16186869
Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men
J Natl Cancer Inst, 97 (14), 1056-66
DOI 10.1093/jnci/dji185, PubMed 16030303
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 125 (1), 41-4
PubMed 15643464
Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
J Natl Cancer Inst Monogr (34), 77-82
DOI 10.1093/jncimonographs/lgi019, PubMed 15784830
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
Br J Cancer, 93 (11), 1209-14
DOI 10.1038/sj.bjc.6602830, PubMed 16251877
[Radical treatment of prostatic cancer in Norway]
Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
PubMed 16244698
Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase
Ann Oncol, 16 (7), 1185-91
DOI 10.1093/annonc/mdi210, PubMed 15849218
High prostate cancer mortality in Norway: influence of Cancer Registry information?
APMIS, 113 (7-8), 542-9
DOI 10.1111/j.1600-0463.2005.apm_245.x, PubMed 16086825
Fatigue in long-term Hodgkin's Disease survivors: a follow-up study
J Clin Oncol, 23 (27), 6587-95
DOI 10.1200/JCO.2005.09.936, PubMed 16170166
Quality of life in long-term Hodgkin's disease survivors with chronic fatigue
Eur J Cancer, 42 (3), 327-33
DOI 10.1016/j.ejca.2005.09.028, PubMed 16377179
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)
J Clin Oncol, 23 (6), 1200-8
DOI 10.1200/JCO.2005.08.003, PubMed 15718317
The management strategies for stage I seminoma
Clin Oncol (R Coll Radiol), 17 (7), 539-42
DOI 10.1016/j.clon.2005.07.002, PubMed 16238141
Chemotherapy in metastatic renal cell cancer
World J Urol, 23 (3), 175-9
DOI 10.1007/s00345-004-0469-x, PubMed 15726382
[Biology and treatment options during the development of prostate cancer]
Tidsskr Nor Laegeforen, 125 (5), 571-4
PubMed 15776028
Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
Eur Urol, 48 (5), 779-85
DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer
J Clin Oncol, 23 (13), 3061-8
DOI 10.1200/JCO.2005.08.048, PubMed 15860864
The Y deletion gr/gr and susceptibility to testicular germ cell tumor
Am J Hum Genet, 77 (6), 1034-43
DOI 10.1086/498455, PubMed 16380914
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
Clin Cancer Res, 11 (12), 4451-9
DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630
Self-reported health and use of health care services in long-term cancer survivors
Int J Cancer, 114 (2), 307-16
DOI 10.1002/ijc.20713, PubMed 15543613
Expression of the epidermal growth factor receptor family in normal and malignant urothelium
BJU Int, 95 (9), 1344-50
DOI 10.1111/j.1464-410X.2005.05497.x, PubMed 15892828
Blood pressure and body mass index in long-term survivors of testicular cancer
J Clin Oncol, 23 (22), 4980-90
DOI 10.1200/JCO.2005.06.882, PubMed 16051950
Is there an association between haemoglobin, depression, and anxiety in cancer patients?
J Psychosom Res, 58 (6), 477-83
DOI 10.1016/j.jpsychores.2005.02.003, PubMed 16125514
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
Cancer Res, 65 (13), 5588-98
DOI 10.1158/0008-5472.CAN-05-0153, PubMed 15994931
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
Eur J Cancer, 42 (1), 50-4
DOI 10.1016/j.ejca.2005.08.032, PubMed 16330205
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample
Support Care Cancer, 13 (8), 637-46
DOI 10.1007/s00520-004-0769-0, PubMed 15756585
Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy
J Clin Oncol, 23 (10), 2378-88
DOI 10.1200/JCO.2005.04.106, PubMed 15800330
Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma
Int J Cancer, 117 (3), 381-6
DOI 10.1002/ijc.21174, PubMed 15900599
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
J Natl Cancer Inst, 97 (18), 1354-65
DOI 10.1093/jnci/dji278, PubMed 16174857
Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer
Eur Urol, 49 (1), 54-8; discussion 58
DOI 10.1016/j.eururo.2005.09.009, PubMed 16314038
Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
J Clin Oncol, 23 (18), 4172-8
DOI 10.1200/JCO.2005.07.114, PubMed 15961764
Publications 2004
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group
J Clin Oncol, 22 (19), 3877-85
DOI 10.1200/JCO.2004.07.089, PubMed 15459209
NY-ESO-1 protein expression and humoral immune responses in prostate cancer
Prostate, 59 (4), 440-7
DOI 10.1002/pros.20025, PubMed 15065093
Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer
Acta Oncol, 43 (2), 134-41
DOI 10.1080/02841860310023174, PubMed 15163161
Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
Ann Oncol, 15 Suppl 4, iv259-65
DOI 10.1093/annonc/mdh936, PubMed 15477318
Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma
Cancer, 101 (3), 533-40
DOI 10.1002/cncr.20307, PubMed 15274066
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
Br J Cancer, 90 (3), 607-12
DOI 10.1038/sj.bjc.6601558, PubMed 14760372
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
Br J Cancer, 90 (2), 449-54
DOI 10.1038/sj.bjc.6601536, PubMed 14735192
Kurativ behandling av prostatacancer i Norge 1997-2001: en analyse basert på data innsamlet av Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 60
BIBSYS 052031810
Prostatakreft i Norge. Insidens, dødelighet og behandling: en deskriptiv analyse av data fra Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 61
BIBSYS 052031896
[Dissemination of evidence-based information about PSA test and prostatic cancer to physicians]
Tidsskr Nor Laegeforen, 124 (22), 2893-5
PubMed 15550959
Somatic mutations of KIT in familial testicular germ cell tumours
Br J Cancer, 90 (12), 2397-401
DOI 10.1038/sj.bjc.6601880, PubMed 15150569
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Ann Oncol, 15 (9), 1377-99
DOI 10.1093/annonc/mdh301, PubMed 15319245
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study
J Urol, 172 (3), 923-7
DOI 10.1097/01.ju.0000135742.13171.d2, PubMed 15310999
Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer
Eur J Surg Oncol, 30 (3), 352-5
DOI 10.1016/j.ejso.2003.09.006, PubMed 15028321
Utvidet registrering av prostatakreft i Norge
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 53
BIBSYS 05203268x
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression
Radiother Oncol, 74 (3), 259-65
DOI 10.1016/j.radonc.2004.12.001, PubMed 15763306
Publications 2003
Extragonadal germ cell tumors: relation to testicular neoplasia and management options
APMIS, 111 (1), 49-59; discussion 59-63
DOI 10.1034/j.1600-0463.2003.11101081.x, PubMed 12752235
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
J Clin Oncol, 21 (5), 871-7
DOI 10.1200/JCO.2003.05.155, PubMed 12610187
Fatigue, anxiety and depression in long-term survivors oftesticular cancer
In Journal of clinical oncology, The Society, Alexandria VA, 21(2003)7, s.1249-54
BIBSYS 041709357
Fatigue, anxiety, and depression in long-term survivors of testicular cancer
J Clin Oncol, 21 (7), 1249-54
DOI 10.1200/JCO.2003.08.163, PubMed 12663711
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
J Clin Oncol, 21 (6), 1107-18
DOI 10.1200/JCO.2003.02.075, PubMed 12637478
Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy
Int J Radiat Oncol Biol Phys, 57 (1), 33-41
DOI 10.1016/s0360-3016(03)00428-0, PubMed 12909213
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
Ann Oncol, 14 (9), 1412-8
DOI 10.1093/annonc/mdg373, PubMed 12954581
Quality of life during radiotherapy for rectal cancer
Eur J Cancer, 39 (5), 587-94
DOI 10.1016/s0959-8049(02)00741-4, PubMed 12628837
Androgen-independent prostate cancer--the clinical problem of a growing pelvic tumour
Acta Oncol, 42 (7), 749-55
DOI 10.1080/02841860310014624, PubMed 14690161
Neuroendocrine serum tumour markers in hormone-resistant prostate cancer
Eur Urol, 44 (2), 215-21
DOI 10.1016/s0302-2838(03)00257-4, PubMed 12875941
Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors
Cancer Genet Cytogenet, 147 (1), 1-8
DOI 10.1016/s0165-4608(03)00160-2, PubMed 14580764
Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
Acta Oncol, 42 (1), 10-4
DOI 10.1080/0891060310002177, PubMed 12665325
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
Int J Cancer, 103 (1), 91-6
DOI 10.1002/ijc.10780, PubMed 12455058
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors
Cancer Res, 63 (22), 7674-8
PubMed 14633689
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
Br J Cancer, 88 (1), 36-41
DOI 10.1038/sj.bjc.6600714, PubMed 12556956
Cancer patients' awareness about their diagnosis: a population-based study
J Public Health Med, 25 (4), 313-7
DOI 10.1093/pubmed/fdg076, PubMed 14747590
Health technology assessment and implications for clinical practice: the case of prostate cancer screening
Scand J Clin Lab Invest, 63 (5), 331-8
DOI 10.1080/00365510310002022, PubMed 14599155
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
J Clin Oncol, 21 (17), 3310-7
DOI 10.1200/JCO.2003.03.184, PubMed 12947067
The impact of demographic and disease-specific variables on pain in cancer patients
J Pain Symptom Manage, 26 (2), 696-704
DOI 10.1016/s0885-3924(03)00239-2, PubMed 12906954
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/s1476-5586(03)80042-8, PubMed 14670177
NKX3.1 expression is lost in testicular germ cell tumors
Am J Pathol, 163 (6), 2149-54
DOI 10.1016/S0002-9440(10)63571-7, PubMed 14633588
Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study
Int J Radiat Oncol Biol Phys, 56 (5), 1397-404
DOI 10.1016/s0360-3016(03)00274-8, PubMed 12873686
The level of physical activity in long-term survivors of testicular cancer
Eur J Cancer, 39 (9), 1216-21
DOI 10.1016/s0959-8049(03)00151-5, PubMed 12763208
Nasjonalt program for prostatacancer (NPPC): målsetting, oppstart og de første erfaringer
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 47
BIBSYS 041735668
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
Urology, 61 (1), 145-51
DOI 10.1016/s0090-4295(02)02107-6, PubMed 12559286
Publications 2002
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis
Ann Oncol, 13 (4), 599-605
DOI 10.1093/annonc/mdf112, PubMed 12056711
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis
J Clin Oncol, 20 (7), 1864-73
DOI 10.1200/JCO.2002.07.062, PubMed 11919246
Analysing longitudinal continuous quality of life data with dropout
Stat Methods Med Res, 11 (1), 5-23
DOI 10.1191/0962280202sm270ra, PubMed 11923994
No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer
J Urol, 168 (3), 1188-92
DOI 10.1016/S0022-5347(05)64623-X, PubMed 12187265
Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
Int J Cancer, 99 (1), 100-5
DOI 10.1002/ijc.10286, PubMed 11948499
Kreft og seksualitet: informasjon til pasienter og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 1/2002 (5. oppl.), 32 s.
BIBSYS 02249751x
Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer
J Psychosom Res, 52 (2), 79-87
DOI 10.1016/s0022-3999(01)00308-7, PubMed 11832253
Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer
In Journal of psychosomatic research, Elsevier, New York, 52(2002)nr 2, s. 79-87
BIBSYS 03128129x
Selection of patients may limit the generalizability of results from cancer trials
Acta Oncol, 41 (2), 131-7
DOI 10.1080/028418602753669490, PubMed 12102156
Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered
Scand J Urol Nephrol, 36 (1), 34-9
DOI 10.1080/003655902317259346, PubMed 12002355
Testikkelkreft: informasjon til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 3/2002, 33 s.
BIBSYS 022497250
Long-term renal function after treatment for malignant germ-cell tumours
Ann Oncol, 13 (2), 222-8
DOI 10.1093/annonc/mdf048, PubMed 11885998
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors
Ann Oncol, 13 (7), 1017-28
DOI 10.1093/annonc/mdf176, PubMed 12176779
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
Eur Urol, 42 (3), 229-38; discussion 237-8
DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507
Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis
Cancer Res, 62 (2), 512-7
PubMed 11809703
Genome profiles of familial/bilateral and sporadic testicular germ cell tumors
Genes Chromosomes Cancer, 34 (2), 168-74
DOI 10.1002/gcc.10058, PubMed 11979550
[Diagnosis and treatment of penile cancer]
Tidsskr Nor Laegeforen, 122 (12), 1194-7
PubMed 12089846
[Lymphedema after surgical treatment of cervical and vulvar cancer]
Tidsskr Nor Laegeforen, 122 (26), 2531-3
PubMed 12522877
Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients
Acta Oncol, 41 (5), 463-70
DOI 10.1080/028418602320405069, PubMed 12442923
'Patient satisfaction' in hospitalized cancer patients
Acta Oncol, 41 (7-8), 639-45
DOI 10.1080/028418602321028256, PubMed 14651208
"Patient satisfaction" in Hospitalized Cancer Patients
In Acta oncologica, Taylor & Francis, Basingstoke, 41(2002)nr 7, s. 639-645
BIBSYS 031282660
New insights into testicular germ cell tumorigenesis from gene expression profiling
Cancer Res, 62 (8), 2359-64
PubMed 11956097
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
Oncogene, 21 (57), 8878-84
DOI 10.1038/sj.onc.1205978, PubMed 12483540
Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score
Hum Pathol, 33 (6), 646-51
DOI 10.1053/hupa.2002.124033, PubMed 12152165
Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact
Eur Urol, 42 (3), 221-8; discussion 228
DOI 10.1016/s0302-2838(02)00310-x, PubMed 12234506
Publications 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome
Cancer, 91 (7), 1394-401
PubMed 11283942
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
J Clin Oncol, 19 (6), 1629-40
DOI 10.1200/JCO.2001.19.6.1629, PubMed 11250991
No randomised trial of prostate-cancer screening in Norway
Lancet Oncol, 2 (12), 741-5; discussion 746-9
DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group
J Clin Oncol, 19 (1), 62-71
DOI 10.1200/JCO.2001.19.1.62, PubMed 11134196
Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer
Eur J Surg Oncol, 27 (7), 645-51
DOI 10.1053/ejso.2001.1195, PubMed 11669593
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis
J Clin Oncol, 19 (6), 1641-8
DOI 10.1200/JCO.2001.19.6.1641, PubMed 11250992
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
J Natl Cancer Inst, 93 (22), 1733-8
DOI 10.1093/jnci/93.22.1733, PubMed 11717334
Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
J Urol, 165 (1), 93-6
DOI 10.1097/00005392-200101000-00023, PubMed 11125372
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer
Prostate, 46 (2), 126-33
DOI 10.1002/1097-0045(20010201)46:2<126::aid-pros1016>3.0.co;2-7, PubMed 11170140
Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
Cancer, 92 (2), 311-9
DOI 10.1002/1097-0142(20010715)92:2<311::aid-cncr1324>3.0.co;2-h, PubMed 11466684
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
BJU Int, 88 (3), 202-8
DOI 10.1046/j.1464-410x.2001.02268.x, PubMed 11488730
TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy
Acta Oncol, 40 (5), 644-52
DOI 10.1080/028418601750444213, PubMed 11669339
Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
Neoplasia, 3 (3), 196-203
DOI 10.1038/sj.neo.7900153, PubMed 11494113
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924
J Clin Oncol, 19 (10), 2638-46
DOI 10.1200/JCO.2001.19.10.2638, PubMed 11352955
Publications 2000
False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer
Acta Oncol, 39 (1), 105-9
DOI 10.1080/028418600431067, PubMed 10752663
The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy
BJU Int, 85 (3), 270-5
DOI 10.1046/j.1464-410x.2000.00406.x, PubMed 10671880
A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09
Int J Radiat Oncol Biol Phys, 47 (2), 379-88
DOI 10.1016/s0360-3016(00)00430-2, PubMed 10802363
Interim analyses in clinical trials: why do we plan them?
J Clin Oncol, 18 (24), 4007-8
DOI 10.1200/JCO.2000.18.24.4007, PubMed 11118460
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
Br J Cancer, 83 (6), 743-9
DOI 10.1054/bjoc.2000.1365, PubMed 10952778
Interferon in metastatic renal cell carcinoma
Semin Oncol, 27 (2), 187-93
PubMed 10768597
Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893
Eur Urol, 37 (5), 541-51
DOI 10.1159/000020191, PubMed 10765092
Fertility in Norwegian testicular cancer patients
Br J Cancer, 82 (3), 737-41
DOI 10.1054/bjoc.1999.0989, PubMed 10682691
[Treatment of renal carcinoma with distant metastases]
Tidsskr Nor Laegeforen, 120 (19), 2274-8
PubMed 10997087
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
Cancer, 88 (11), 2629-35
DOI 10.1002/1097-0142(20000601)88:11<2629::AID-CNCR27>3.3.CO;2-6, PubMed 10861442
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
J Natl Cancer Inst, 92 (1), 54-61
DOI 10.1093/jnci/92.1.54, PubMed 10620634
Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours
Ann Oncol, 11 (7), 897-8
DOI 10.1023/a:1008311532043, PubMed 10997823
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors
BJU Int, 86 (3), 240-7
DOI 10.1046/j.1464-410x.2000.00767.x, PubMed 10930923
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
Br J Cancer, 83 (12), 1623-9
DOI 10.1054/bjoc.2000.1498, PubMed 11104556
Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle
Eur Urol, 38 (6), 725-6;discussion 727
DOI 10.1159/000020369, PubMed 11111191
Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation
Radiother Oncol, 57 (2), 195-200
DOI 10.1016/s0167-8140(00)00219-x, PubMed 11054523
Gastrointestinal presentation of germ cell malignancy
Eur Urol, 38 (6), 721-4
DOI 10.1159/000020368, PubMed 11111190
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Nat Genet, 24 (2), 197-200
DOI 10.1038/72877, PubMed 10655070
Carcinoma in situ in the testis
Scand J Urol Nephrol Suppl (205), 166-86
DOI 10.1080/00365590050509896, PubMed 11144894
Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
J Psychosom Res, 49 (1), 27-34
DOI 10.1016/s0022-3999(00)00080-5, PubMed 11053601
Anxiety and depression in cancer patients : relation between the hospital anxiety and depression scale and the european organization for research and treatment of cancer core quality of life questionnaire
In Journal of psychosomatic research, Elsevier, New York, s. 27-34
BIBSYS 01070535x
[PSA analyses in three Norwegian counties in 1999]
Tidsskr Nor Laegeforen, 120 (21), 2539-41
PubMed 11070992
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy
Radiology, 215 (2), 437-44
DOI 10.1148/radiology.215.2.r00ma02437, PubMed 10796922
Publications 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party
J Natl Cancer Inst, 91 (10), 839-46
DOI 10.1093/jnci/91.10.839, PubMed 10340903
Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
Int J Radiat Oncol Biol Phys, 43 (2), 385-91
DOI 10.1016/s0360-3016(98)00400-3, PubMed 10030266
Is "optimal" radiation for stage I seminoma yet defined? In reply
J. Clin. Oncol., 17 (9), 3005
Good quality of life in prostate cancer patients: how can it be obtained?
Scand J Urol Nephrol Suppl, 203, 51-2
DOI 10.1080/003655999750169385-1, PubMed 10636571
Treatment outcome of patients with brain metastases from malignant germ cell tumors
Cancer, 85 (4), 988-97
DOI 10.1002/(sici)1097-0142(19990215)85:4<988::aid-cncr29>3.0.co;2-r, PubMed 10091779
Health-related quality of life in patients treated for testicular cancer
Curr Opin Urol, 9 (5), 425-9
DOI 10.1097/00042307-199909000-00010, PubMed 10579081
[Timely screening routines for prostatic cancer by Norwegian physicians]
Tidsskr Nor Laegeforen, 119 (24), 3572-6
PubMed 10563174
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group
J Clin Oncol, 17 (4), 1146
DOI 10.1200/JCO.1999.17.4.1146, PubMed 10561173
Androgen replacement and quality of life in patients treated for bilateral testicular cancer
Eur J Cancer, 35 (8), 1220-5
DOI 10.1016/s0959-8049(99)00123-9, PubMed 10615233
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
Br J Cancer, 80 (9), 1392-9
DOI 10.1038/sj.bjc.6690534, PubMed 10424741
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
Br J Cancer, 80 (1-2), 249-55
DOI 10.1038/sj.bjc.6690347, PubMed 10390004
Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study
APMIS, 107 (3), 297-302
DOI 10.1111/j.1699-0463.1999.tb01557.x, PubMed 10223302
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
Int J Radiat Oncol Biol Phys, 43 (4), 735-43
DOI 10.1016/s0360-3016(98)00475-1, PubMed 10098428
Defining an international research agenda for quality of life in men with prostate cancer
Prostate, 41 (1), 58-67
DOI 10.1002/(sici)1097-0045(19990915)41:1<58::aid-pros8>3.0.co;2-3, PubMed 10440876
Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy
Eur Urol, 36 (2), 116-22
DOI 10.1159/000067982, PubMed 10420032
Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer
Oncol Rep, 6 (5), 1001-7
DOI 10.3892/or.6.5.1001, PubMed 10425294
Publications 1998
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors
Cancer Res, 58 (10), 2087-90
PubMed 9605748
Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients
Anticancer Drugs, 9 (2), 125-9
DOI 10.1097/00001813-199802000-00002, PubMed 9510497
Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94
Br J Cancer, 77 (2), 329-35
DOI 10.1038/bjc.1998.51, PubMed 9461006
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
J Clin Oncol, 16 (2), 716-24
DOI 10.1200/JCO.1998.16.2.716, PubMed 9469362
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma
Eur J Cancer, 34 (7), 1131-2
DOI 10.1016/s0959-8049(97)10156-3, PubMed 9849467
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group
J Urol, 160 (4), 1353-7
PubMed 9751353
Radiation-induced insufficiency fractures after definitive prostate cancer radiotherapy
Acta Oncol, 37 (2), 201-2
DOI 10.1080/028418698429775, PubMed 9636016
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
J Clin Oncol, 16 (2), 692-701
DOI 10.1200/JCO.1998.16.2.692, PubMed 9469359
Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study
Br J Urol, 81 (6), 862-9
DOI 10.1046/j.1464-410x.1998.00657.x, PubMed 9666772
[Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer]
Tidsskr Nor Laegeforen, 118 (22), 3401-5
PubMed 9800488
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia
J Urol, 159 (5), 1599-605
DOI 10.1097/00005392-199805000-00051, PubMed 9554362
Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma
Int J Oncol, 12 (5), 1091-6
DOI 10.3892/ijo.12.5.1091, PubMed 9538134
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
Cancer, 83 (7), 1409-19
DOI 10.1002/(SICI)1097-0142(19981001)83:7<1409::AID-CNCR19>3.3.CO;2-1, PubMed 9762943
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
J Clin Oncol, 16 (1), 269-74
DOI 10.1200/JCO.1998.16.1.269, PubMed 9440752
Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995
Cancer Causes Control, 9 (5), 475-86
DOI 10.1023/a:1008857702380, PubMed 9934714
[Occurrence of anxiety and depression in cancer patients. An investigation at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 118 (5), 698-703
PubMed 9528365
Publications 1997
How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
Urology, 49 (4A Suppl), 66-76
DOI 10.1016/s0090-4295(99)80325-2, PubMed 9111616
Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)
Eur J Cancer, 33 (11), 1809-14
DOI 10.1016/s0959-8049(97)00187-1, PubMed 9470838
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors
Eur J Cancer, 33 (3), 493-5
DOI 10.1016/s0959-8049(97)89027-2, PubMed 9155537
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
Eur J Cancer, 33 (6), 829-35
DOI 10.1016/s0959-8049(97)00033-6, PubMed 9291801
Residual androgen depending in hormone-resistant prostate cancer
Acta Oncol, 36 (1), 81-2
DOI 10.3109/02841869709100739, PubMed 9090973
Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assay
Cytometry, 30 (4), 192-6
PubMed 9298838
Current status of chemotherapy in advanced seminoma
Eur J Cancer, 33 (2), 181-3
DOI 10.1016/s0959-8049(96)00281-x, PubMed 9135484
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
Eur J Cancer, 33 (9), 1380-7
DOI 10.1016/s0959-8049(96)00425-x, PubMed 9337678
Influence of urological morbidity on quality of life in patients with prostate cancer
Eur Urol, 31 Suppl 3, 3-8
DOI 10.1159/000474553, PubMed 9101208
A segregation analysis of testicular cancer based on Norwegian and Swedish families
Br J Cancer, 75 (7), 1084-7
DOI 10.1038/bjc.1997.185, PubMed 9083348
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study
Eur J Oral Sci, 105 (5 Pt 2), 523-6
DOI 10.1111/j.1600-0722.1997.tb00239.x, PubMed 9395118
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study
Br J Cancer, 76 (1), 93-9
DOI 10.1038/bjc.1997.342, PubMed 9218739
Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy
Eur Urol, 31 (2), 141-7
DOI 10.1159/000474439, PubMed 9076455
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
J Clin Oncol, 15 (5), 1844-52
DOI 10.1200/JCO.1997.15.5.1844, PubMed 9164194
External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
Int J Radiat Oncol Biol Phys, 38 (1), 95-102
DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
Pathol Res Pract, 193 (7), 471-8
DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752
Assessment of hormone refractory prostate cancer
Urology, 49 (4A Suppl), 46-53
DOI 10.1016/s0090-4295(99)80323-9, PubMed 9111614
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma
Eur J Cancer, 33 (3), 496-9
DOI 10.1016/s0959-8049(97)89028-4, PubMed 9155538
[Primary invasive breast cancer in Oslo 1980-89. A population based study of 1942 unselected patients treated by radical surgery]
Tidsskr Nor Laegeforen, 117 (26), 3778-83
PubMed 9417680
Hospital-related differences in breast cancer management. Analysis of an unselected population-based series of 1353 radically operated patients
Breast Cancer Res Treat, 43 (3), 225-35
DOI 10.1023/a:1005730327487, PubMed 9150902
Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma--a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989
Acta Oncol, 36 (3), 255-60
DOI 10.3109/02841869709001259, PubMed 9208893
Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area
APMIS, 105 (5), 363-70
DOI 10.1111/j.1699-0463.1997.tb00582.x, PubMed 9201237
Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC)
Ann Oncol, 8 (7), 695-6
DOI 10.1023/a:1008269432176, PubMed 9296225
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group
J Urol, 158 (2), 474-8
DOI 10.1016/s0022-5347(01)64506-3, PubMed 9224327
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group
Cancer, 79 (2), 345-55
PubMed 9010108
Postradiation lower motor neuron syndrome--a case report and brief literature review
Acta Oncol, 36 (3), 345-7
DOI 10.3109/02841869709001276, PubMed 9208910
Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients
Eur J Cancer, 33 (2), 244-52
DOI 10.1016/s0959-8049(96)00459-5, PubMed 9135496
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
Eur J Cancer, 33 (2), 253-62
DOI 10.1016/s0959-8049(96)00458-3, PubMed 9135497
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital
Eur J Cancer, 33 (10), 1597-604
DOI 10.1016/s0959-8049(97)00054-3, PubMed 9389921
Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients
Radiother Oncol, 45 (2), 125-8
DOI 10.1016/s0167-8140(97)00099-6, PubMed 9424001
Publications 1996
Follow-up of prostatic intraepithelial neoplasia
Eur Urol, 30 (2), 256-60
DOI 10.1159/000474177, PubMed 8875208
Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer
Br J Urol, 77 (1), 36-40
DOI 10.1046/j.1464-410x.1996.08467.x, PubMed 8653315
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report
J Clin Oncol, 14 (4), 1106-13
DOI 10.1200/JCO.1996.14.4.1106, PubMed 8648364
The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853
Eur J Cancer, 32A (1), 72-7
DOI 10.1016/0959-8049(95)00402-5, PubMed 8695246
Survival after curative treatment of muscle-invasive bladder cancer
Acta Oncol, 35 Suppl 8, 59-65
DOI 10.3109/02841869609098521, PubMed 9073049
Quality of life in prostate cancer: what are the issues and how are they measured?
Eur Urol, 29 Suppl 2, 121-3
DOI 10.1159/000473852, PubMed 8717474
Quality of life in advanced prostate cancer
Semin Oncol, 23 (6 Suppl 14), 32-4
PubMed 8996583
Does the service at a large oncologic out-patient clinic satisfy the patients' perceived need?
Int J Health Care Qual Assur, 9 (4), 24-9
DOI 10.1108/09526869610124209, PubMed 10159575
Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study
Support Care Cancer, 4 (2), 118-28
DOI 10.1007/BF01845761, PubMed 8673349
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
Br J Cancer, 74 (10), 1655-9
DOI 10.1038/bjc.1996.605, PubMed 8932351
Familial testicular cancer in Norway and southern Sweden
Br J Cancer, 73 (7), 964-9
DOI 10.1038/bjc.1996.173, PubMed 8611416
Risk of cancer in relatives of testicular cancer patients
Br J Cancer, 73 (7), 970-3
DOI 10.1038/bjc.1996.174, PubMed 8611417
Skin lesions and G-CSF in patients with malignant diseases. Malignancy or cutaneous side-effect?
Eur J Cancer, 32A (3), 554-5
DOI 10.1016/0959-8049(95)00595-1, PubMed 8814708
[Increased incidence of prostatic cancer. The significance of prostate-specific antigen]
Tidsskr Nor Laegeforen, 116 (15), 1795-9
PubMed 8693464
Primary invasive breast carcinoma in Oslo 1980-1989. Incidence and delay
Acta Oncol, 35 (1), 9-15
DOI 10.3109/02841869609098473, PubMed 8619947
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
J Exp Ther Oncol, 1 (3), 155-61
PubMed 9414399
Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer
Br J Cancer, 74 (9), 1492-8
DOI 10.1038/bjc.1996.571, PubMed 8912551
Publications 1995
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
J Pathol, 176 (3), 299-308
DOI 10.1002/path.1711760312, PubMed 7674092
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma
Br J Urol, 75 (1), 26-32
DOI 10.1111/j.1464-410x.1995.tb07227.x, PubMed 7531589
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group
Eur J Cancer, 31A (10), 1622-6
DOI 10.1016/0959-8049(95)00193-m, PubMed 7488412
Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage t0 to 4,N1 to 3.M0,D1). European Organization for Research and Treatment of Cancer Genitourinary Group
J Urol, 154 (6), 2118-22
DOI 10.1016/S0022-5347(01)66711-9, PubMed 7500472
Interferon-alpha and survival in renal cell cancer
Br J Urol, 76 (3), 286-90
DOI 10.1111/j.1464-410x.1995.tb07702.x, PubMed 7551834
[Treatment of testicular cancer in regional health care]
Tidsskr Nor Laegeforen, 115 (19), 2435-7
PubMed 7667865
[Tumor cells in peripheral blood and bone marrow in patients with prostatic cancer. Many unanswered questions]
Tidsskr Nor Laegeforen, 115 (29), 3599-600
PubMed 8539709
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group
Br J Cancer, 71 (3), 619-24
DOI 10.1038/bjc.1995.121, PubMed 7880748
Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer
Oncology, 52 (4), 300-5
DOI 10.1159/000227478, PubMed 7539902
Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
Acta Oncol, 34 (5), 599-603
DOI 10.3109/02841869509094034, PubMed 7546824
The place of radiation therapy as definitive treatment of bladder cancer
Int J Urol, 2 Suppl 2, 41-8
DOI 10.1111/j.1442-2042.1995.tb00478.x, PubMed 7553304
Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population
Cancer Epidemiol Biomarkers Prev, 4 (2), 123-6
PubMed 7742719
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire
J Clin Oncol, 13 (5), 1249-54
DOI 10.1200/JCO.1995.13.5.1249, PubMed 7738629
Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer
Br J Urol, 75 (4), 502-6
DOI 10.1111/j.1464-410x.1995.tb07273.x, PubMed 7540482
Molecular genetic changes in human male germ cell tumors
Lab Invest, 73 (5), 606-14
PubMed 7474934
The burden of prostate cancer from diagnosis until death
Br J Urol, 76 (5), 587-94
DOI 10.1111/j.1464-410x.1995.tb07783.x, PubMed 8535677
Prostate cancer in the era of prostate-specific antigen
Curr Opin Oncol, 7 (3), 281-91
DOI 10.1097/00001622-199505000-00014, PubMed 7544627
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups
J Clin Oncol, 13 (5), 1177-87
DOI 10.1200/JCO.1995.13.5.1177, PubMed 7537801
Trends in incidence of testicular cancer in Norway 1955-1992
Eur J Cancer, 31A (12), 2044-8
DOI 10.1016/0959-8049(95)00321-5, PubMed 8562163
Publications 1994
Prostatic carcinoma: a multivariate analysis of prognostic factors
Br J Cancer, 69 (5), 924-30
DOI 10.1038/bjc.1994.179, PubMed 7514029
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV
Eur Urol, 26 (4), 334-9
DOI 10.1159/000475410, PubMed 7713133
The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract
Semin Oncol, 21 (1 Suppl 1), 65-9
PubMed 7512278
Quality-of-life assessment in unselected oncologic out-patients - a pilot-study
Int J Oncol, 4 (6), 1393-7
DOI 10.3892/ijo.4.6.1393, PubMed 21567068
Management of hormone resistant prostate cancer
Acta Urol Belg, 62 (1), 73-6
PubMed 7515211
Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience
Br J Urol, 74 (3), 345-51
DOI 10.1111/j.1464-410x.1994.tb16625.x, PubMed 7524999
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
Br J Cancer, 70 (6), 1156-60
DOI 10.1038/bjc.1994.464, PubMed 7981068
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha
Eur J Cancer, 30A (9), 1310-4
DOI 10.1016/0959-8049(94)90179-1, PubMed 7999419
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report
Eur Urol, 26 (1), 29-34
DOI 10.1159/000475338, PubMed 7523131
Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer
Br J Urol, 74 (3), 359-65
DOI 10.1111/j.1464-410x.1994.tb16627.x, PubMed 7953268
Second cancer after treatment of malignant germ-cell tumors
World J Urol, 12 (3), 151-4
DOI 10.1007/BF00192277, PubMed 7951342
Assessment of quality of life in patients with prostate cancer
Semin Oncol, 21 (5), 657-61
PubMed 7524156
Pharmacokinetics of Carboplatin in a patient with both testicular cancer and hemodialysis-requiring kidney failure
Int J Oncol, 4 (2), 359-62
DOI 10.3892/ijo.4.2.359, PubMed 21566932
Genetic factors in malignant germ-cell tumors
World J Urol, 12 (4), 178-81
DOI 10.1007/BF00185667, PubMed 7820137
Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer
Int J Cancer, 58 (4), 523-6
DOI 10.1002/ijc.2910580412, PubMed 8056449
Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study
Ann Oncol, 5 (3), 245-8
DOI 10.1093/oxfordjournals.annonc.a058801, PubMed 8186172
Metastases from renal cell carcinoma to the humerus or the shoulder girdle
Br J Urol, 73 (2), 124-8
DOI 10.1111/j.1464-410x.1994.tb07478.x, PubMed 8131012
[Screening for early diagnosis of prostatic cancer]
Tidsskr Nor Laegeforen, 114 (9), 1104-5
PubMed 8009529
Quality of life in patients treated for penile cancer. A follow-up study
Br J Urol, 74 (5), 652-7
DOI 10.1111/j.1464-410x.1994.tb09200.x, PubMed 7827818
Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement
Br J Urol, 73 (5), 554-60
DOI 10.1111/j.1464-410x.1994.tb07643.x, PubMed 8012779
Toxicity in long-term survivors after adriamycin containing chemotherapy of malignant germ-cell tumors
Int J Oncol, 4 (3), 681-8
DOI 10.3892/ijo.4.3.681, PubMed 21566977
Combined single course carboplatin with radiotherapy in treatment of stage IIA,B seminoma--a preliminary report
Radiother Oncol, 33 (1), 88-90
DOI 10.1016/0167-8140(94)90092-2, PubMed 7878216
Aims and results of palliative radiotherapy in urological cancer
Curr Opin Oncol, 6 (3), 308-12
DOI 10.1097/00001622-199405000-00014, PubMed 7521671
Publications 1993
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry
Anal Cell Pathol, 5 (6), 339-52
PubMed 8305330
DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas
Anal Quant Cytol Histol, 15 (4), 247-52
PubMed 7691062
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
Histopathology, 22 (4), 327-33
DOI 10.1111/j.1365-2559.1993.tb00131.x, PubMed 8099896
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens
Br J Cancer, 68 (2), 380-4
DOI 10.1038/bjc.1993.344, PubMed 7688548
Meningeal tumour infiltration in hormone resistant prostate cancer demonstrated with magnetic resonance
Eur J Cancer, 29A (9), 1357
DOI 10.1016/0959-8049(93)90094-v, PubMed 8343288
Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma
Eur J Cancer, 29A (9), 1313-5
DOI 10.1016/0959-8049(93)90080-y, PubMed 8343275
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
Br J Cancer, 68 (3), 572-8
DOI 10.1038/bjc.1993.388, PubMed 8102536
Quality control of computed tomograms in testicular tumours
Lancet, 341 (8861), 1666
DOI 10.1016/0140-6736(93)90806-r, PubMed 8100034
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
Cancer, 72 (10), 3036-43
DOI 10.1002/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b, PubMed 8221571
Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
Radiother Oncol, 27 (1), 63-5
DOI 10.1016/0167-8140(93)90046-b, PubMed 8327735
Semen quality after treatment for testicular cancer
Eur Urol, 23 (1), 172-6
DOI 10.1159/000474589, PubMed 8477777
Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy
Radiother Oncol, 27 (2), 117-22
DOI 10.1016/0167-8140(93)90131-q, PubMed 8356221
Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report
Eur Urol, 23 (1), 115-8; discussion 119
DOI 10.1159/000474578, PubMed 8477771
Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours
Br J Urol, 71 (2), 214-6
DOI 10.1111/j.1464-410x.1993.tb15921.x, PubMed 8384915
Urologic cancer in elderly patients
Curr Opin Oncol, 5 (3), 568-73
DOI 10.1097/00001622-199305000-00019, PubMed 8494916
No germline TP53 mutations detected in familial and bilateral testicular cancer
Genes Chromosomes Cancer, 6 (2), 92-7
DOI 10.1002/gcc.2870060205, PubMed 7680893
Salvage treatment in male patients with germ cell tumours
Br J Cancer, 67 (3), 568-72
DOI 10.1038/bjc.1993.104, PubMed 8382512
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer
J Clin Oncol, 11 (4), 607-15
DOI 10.1200/JCO.1993.11.4.607, PubMed 7683043
Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin
Br J Cancer, 68 (3), 555-8
DOI 10.1038/bjc.1993.385, PubMed 7688978
Frequent loss of 11p13 and 11p15 loci in male germ cell tumours
Genes Chromosomes Cancer, 7 (2), 96-101
DOI 10.1002/gcc.2870070206, PubMed 7687459
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)
J Urol, 150 (6), 1840-4
DOI 10.1016/s0022-5347(17)35911-6, PubMed 8230517
Flow cytometric DNA analysis as prognostic factor in human breast carcinoma
Pathol Res Pract, 189 (4), 405-10
DOI 10.1016/S0344-0338(11)80327-4, PubMed 8351241
K-ras oncogene codon 12 point mutations in testicular cancer
Environ Health Perspect, 101 Suppl 3 (Suppl 3), 185-7
DOI 10.1289/ehp.101-1521158, PubMed 8143614
Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I
Scand J Urol Nephrol, 27 (3), 355-62
DOI 10.3109/00365599309180447, PubMed 8290916
Rare Ha-ras1 alleles and predisposition to testicular cancer
Int J Cancer, 53 (6), 938-40
DOI 10.1002/ijc.2910530612, PubMed 8097187
Role of ondansetron plus dexamethasone in fractionated chemotherapy
Oncology, 50 (3), 168-72
DOI 10.1159/000227172, PubMed 8459987
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
Ann Oncol, 4 (5), 403-7
DOI 10.1093/oxfordjournals.annonc.a058520, PubMed 8353075
Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group
J Urol, 150 (2 Pt 1), 400-6
DOI 10.1016/s0022-5347(17)35493-9, PubMed 8326563
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
Cancer, 72 (10), 3044-51
DOI 10.1002/1097-0142(19931115)72:10<3044::aid-cncr2820721029>3.0.co;2-d, PubMed 8221572
[Treatment of threatened spinal cord lesions in patients with prostatic cancer]
Tidsskr Nor Laegeforen, 113 (17), 2141
PubMed 8337680
Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation
Br J Cancer, 67 (5), 1113-7
DOI 10.1038/bjc.1993.204, PubMed 8494708
Publications 1992
5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group
Ann Oncol, 3 (5), 399-400
DOI 10.1093/oxfordjournals.annonc.a058216, PubMed 1377488
PROSTATE-CANCER - IMAGING, MANAGEMENT, AND SCREENING - PROCEEDINGS OF THE PROSTATE SESSIONS AT THE 1ST INTERNATIONAL-CONGRESS OF THE DUTCH-UROLOGICAL-ASSOCIATION (NVU) HELD IN ROTTERDAM, THE NETHERLANDS OCTOBER 9-13, 1991 - ROUND-TABLE DISCUSSION
Prostate (4), 59-62
Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer
Br J Urol, 69 (1), 108
PubMed 1371085
Rare and unusual tumors of the genitourinary tract
Curr Opin Oncol, 4 (3), 463-8
DOI 10.1097/00001622-199206000-00006, PubMed 1323334
DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories
Cytometry, 13 (4), 395-403
DOI 10.1002/cyto.990130410, PubMed 1526198
Prognostic factors in hormone-resistant progressing cancer of the prostate
Ann Oncol, 3 (5), 361-6
DOI 10.1093/oxfordjournals.annonc.a058207, PubMed 1616889
Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group
Eur J Cancer, 28A (4-5), 878-80
DOI 10.1016/0959-8049(92)90139-s, PubMed 1524914
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)
Br J Urol, 70 (2), 161-8
DOI 10.1111/j.1464-410x.1992.tb15696.x, PubMed 1393439
Neuron-specific enolase--a serum tumour marker in seminoma?
Br J Cancer, 65 (2), 297-9
DOI 10.1038/bjc.1992.59, PubMed 1739633
Quality of life in prostate cancer patients
Prostate Suppl, 4, 145-8
DOI 10.1002/pros.2990210523, PubMed 1574455
Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies
Int J Cancer, 50 (6), 868-70
DOI 10.1002/ijc.2910500606, PubMed 1372881
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study
Ann Oncol, 3 (4), 301-5
DOI 10.1093/oxfordjournals.annonc.a058185, PubMed 1390305
Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer
Scand J Urol Nephrol, 26 (2), 131-8
DOI 10.1080/00365599.1992.11690444, PubMed 1626202
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment
Br J Urol, 69 (2), 175-9
DOI 10.1111/j.1464-410x.1992.tb15491.x, PubMed 1371425
89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes
Br J Cancer, 66 (1), 177-80
DOI 10.1038/bjc.1992.238, PubMed 1379058
Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer
Lancet, 340 (8834-8835), 1544
DOI 10.1016/0140-6736(92)92794-g, PubMed 1281904
Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
J Clin Oncol, 10 (4), 569-73
DOI 10.1200/JCO.1992.10.4.569, PubMed 1312586
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer
Br J Cancer, 66 (1), 181-4
DOI 10.1038/bjc.1992.239, PubMed 1379059
Asymmetrical autonomic dysfunction of the feet after retroperitoneal surgery in patients with testicular cancer: 2 case reports
J Urol, 147 (2), 470-1
DOI 10.1016/s0022-5347(17)37278-6, PubMed 1732625
No evidence for constitutional chromosome instability in testicular cancer
Hum Genet, 89 (3), 338-40
DOI 10.1007/BF00220554, PubMed 1318262
DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report
Eur Urol, 22 (4), 316-22
DOI 10.1159/000474779, PubMed 1490510
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy
J Urol, 147 (1), 34-7
DOI 10.1016/s0022-5347(17)37127-6, PubMed 1729547
High resolution chromosome banding in search of germ line mutations applied on testicular cancer patients
Cancer Genet Cytogenet, 59 (1), 62-7
DOI 10.1016/0165-4608(92)90160-a, PubMed 1555193
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party
J Clin Oncol, 10 (1), 85-94
DOI 10.1200/JCO.1992.10.1.85, PubMed 1309383
Chromosome 12 in human testicular cancer: dosage changes and their parental origin
Cancer Genet Cytogenet, 64 (1), 21-6
DOI 10.1016/0165-4608(92)90316-z, PubMed 1458445
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor
J Surg Oncol, 50 (4), 220-3
DOI 10.1002/jso.2930500404, PubMed 1640703
Carcinoma of the renal pelvis. Experience of 80 cases
Scand J Urol Nephrol, 26 (4), 357-61
DOI 10.3109/00365599209181226, PubMed 1292073
Cisplatin and 5-fluorouracil in advanced cancer of the penis
J Urol, 147 (3), 630-2
DOI 10.1016/s0022-5347(17)37327-5, PubMed 1538445
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials Group
Ann Oncol, 3 (7), 577-8
DOI 10.1093/oxfordjournals.annonc.a058266, PubMed 1323325
Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer
J Urol, 148 (3), 838-41; discussion 841-2
DOI 10.1016/s0022-5347(17)36737-x, PubMed 1512835
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer
Eur Urol, 22 (1), 33-8
DOI 10.1159/000474718, PubMed 1385143
Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study
Int J Radiat Oncol Biol Phys, 22 (5), 1057-64
DOI 10.1016/0360-3016(92)90808-u, PubMed 1555953
Publications 1991
CT in primary malignant germ cell tumors of the retroperitoneum
Acta Radiol, 32 (2), 155-8
DOI 10.3109/02841859109177536, PubMed 1851626
Pelvic palliation radiotherapy of advanced bladder cancer
Int J Radiat Oncol Biol Phys, 20 (6), 1379
DOI 10.1016/0360-3016(91)90254-2, PubMed 1710614
Penile and adrenal cancer
Curr Opin Oncol, 3 (3), 565-7
DOI 10.1097/00001622-199106000-00020, PubMed 1892924
Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect
Acta Oncol, 30 (6), 735-8
DOI 10.3109/02841869109092449, PubMed 1958395
Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma
N Engl J Med, 324 (9), 633-4
DOI 10.1056/NEJM199102283240913, PubMed 1992326
DNA flow cytometry in sperm cells from testicular cancer patients. Impact of different treatment modalities on spermatogenesis
Eur Urol, 19 (2), 125-31
DOI 10.1159/000473600, PubMed 2022215
DNA ploidy in primary testicular cancer
Br J Cancer, 64 (5), 948-52
DOI 10.1038/bjc.1991.432, PubMed 1931622
DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I
Cancer, 67 (7), 1874-7
DOI 10.1002/1097-0142(19910401)67:7<1874::aid-cncr2820670710>3.0.co;2-6, PubMed 1848470
Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy
Br J Urol, 67 (1), 54-60
DOI 10.1111/j.1464-410x.1991.tb15070.x, PubMed 1993277
Long-term morbidity and quality of life in testicular cancer patients
Scand J Urol Nephrol Suppl, 138, 241-6
PubMed 1785014
Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study
Br J Cancer, 63 (4), 550-2
DOI 10.1038/bjc.1991.129, PubMed 1850610
Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor
Cancer Genet Cytogenet, 57 (1), 41-6
DOI 10.1016/0165-4608(91)90187-y, PubMed 1756483
Colony formation in urinary bladder carcinoma. Relationship to DNA flow cytometry, stage and histopathology
Anticancer Res, 11 (2), 777-81
PubMed 2064333
Psychosocial well-being in testicular cancer patients
Eur J Cancer, 27 (9), 1091-5
DOI 10.1016/0277-5379(91)90299-s, PubMed 1683558
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours
Ann Oncol, 2 (3), 203-11
DOI 10.1093/oxfordjournals.annonc.a057906, PubMed 1710482
Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate
Radiology, 179 (2), 547-50
DOI 10.1148/radiology.179.2.2014309, PubMed 2014309
Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients
Br J Cancer, 64 (2), 401-5
DOI 10.1038/bjc.1991.317, PubMed 1892774
Altered dosage of the sex chromosomes in human testicular cancer: a molecular genetic study
Int J Cancer, 47 (4), 518-22
DOI 10.1002/ijc.2910470408, PubMed 1995482
Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
J Urol, 145 (2), 300-2; discussion 302-3
DOI 10.1016/s0022-5347(17)38321-0, PubMed 1988722
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder
Br J Urol, 68 (2), 162-8
DOI 10.1111/j.1464-410x.1991.tb15287.x, PubMed 1884143
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study
Eur J Cancer, 27 (12), 1583-9
DOI 10.1016/0277-5379(91)90419-e, PubMed 1782066
Prediction of long-term gonadal toxicity after standard treatment for testicular cancer
Eur J Cancer, 27 (9), 1087-91
DOI 10.1016/0277-5379(91)90298-r, PubMed 1720322
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
J Clin Oncol, 9 (5), 818-26
DOI 10.1200/JCO.1991.9.5.818, PubMed 1707957
Publications 1990
Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study
Strahlenther Onkol, 166 (9), 580-3
PubMed 2120783
Metastatic testicular cancer and extragonadal germ cell tumor presenting with neurological symptoms
J Neurooncol, 8 (2), 145-8
DOI 10.1007/BF00177837, PubMed 2162914
Penile and adrenal cancer
Curr Opin Oncol, 2 (3), 533-6
PubMed 2092771
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study
Cancer, 65 (11), 2451-4
DOI 10.1002/1097-0142(19900601)65:11<2451::aid-cncr2820651108>3.0.co;2-3, PubMed 2337859
Serum levels of sex hormone binding globulin and oestradiol in patients with testicular cancer
Br J Urol, 66 (5), 518-22
DOI 10.1111/j.1464-410x.1990.tb15001.x, PubMed 2249122
Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug
J Urol, 143 (3), 498-501
DOI 10.1016/s0022-5347(17)40001-2, PubMed 2304161
Flutamide in hormone-resistant prostatic cancer
J Urol, 144 (6), 1411-4
DOI 10.1016/s0022-5347(17)39756-2, PubMed 1700154
[Penile cancer]
Tidsskr Nor Laegeforen, 110 (11), 1354-6
PubMed 1692641
Long-term side effects after treatment of testicular cancer
Prog Clin Biol Res, 357, 321-30
PubMed 2217475
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy
Br J Cancer, 61 (4), 639-43
DOI 10.1038/bjc.1990.142, PubMed 2109999
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma
Acta Oncol, 29 (3), 303-6
DOI 10.3109/02841869009090002, PubMed 2363942
Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I
Eur Urol, 17 (2), 107-12
DOI 10.1159/000464016, PubMed 2155789
Management of patients with poor-prognosis nonseminomatous germ cell cancer
Oncology, 47 (3), 234-40
DOI 10.1159/000226822, PubMed 1692984
Cisplatin and medium dose methotrexate in advanced transitional cell carcinoma of the urinary tract
Scand J Urol Nephrol, 24 (3), 199-204
DOI 10.3109/00365599009180858, PubMed 2237296
Recovery of impaired pretreatment spermatogenesis in testicular cancer
Fertil Steril, 54 (3), 493-6
DOI 10.1016/s0015-0282(16)53768-6, PubMed 2118861
Assessment of quality of life and subjective response criteria in patients with prostatic cancer
Prog Clin Biol Res, 357, 199-202
PubMed 2217464
Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group
Eur J Cancer, 26 (11-12), 1133-6
DOI 10.1016/0277-5379(90)90269-y, PubMed 2149995
Basic principles of clinical trials as applied to testicular cancer
Prog Clin Biol Res, 357, 255-66
PubMed 2217470
Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987
Br J Cancer, 62 (2), 277-8
DOI 10.1038/bjc.1990.277, PubMed 2386743
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma
J Urol, 143 (4), 706-9
DOI 10.1016/s0022-5347(17)40066-8, PubMed 2313795
Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer, 26 (5), 646
DOI 10.1016/0277-5379(90)90099-f, PubMed 2144757
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)
Ann Oncol, 1 (4), 281-8
DOI 10.1093/oxfordjournals.annonc.a057749, PubMed 1702312
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 8 (3), 509-18
DOI 10.1200/JCO.1990.8.3.509, PubMed 1689773
[Locally advanced breast cancer--primary treatment with tamoxifen]
Tidsskr Nor Laegeforen, 110 (14), 1815-6
PubMed 2363143
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865
J Steroid Biochem Mol Biol, 37 (6), 971-5
DOI 10.1016/0960-0760(90)90452-q, PubMed 2126739
Sensitivity to short-term chemotherapy in patients with bladder cancer evaluated by computed tomography of the primary tumor
Prog Clin Biol Res, 353, 203-12
PubMed 2217420
Computed tomography of the urinary bladder shortly after radiation therapy for rectal carcinoma
Acta Radiol, 31 (6), 585-8
PubMed 2278782
Prognostic factors in metastatic germ cell tumors
Prog Clin Biol Res, 357, 313-9
PubMed 2170996
Serum follicle stimulating hormone--predictor of cancer in the remaining testis in patients with unilateral testicular cancer
Br J Urol, 66 (3), 315-7
DOI 10.1111/j.1464-410x.1990.tb14935.x, PubMed 2119845
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
Br J Urol, 65 (4), 385-90
DOI 10.1111/j.1464-410x.1990.tb14762.x, PubMed 2340372
Prognosis in patients with metastatic non-seminomatous testicular cancer
Radiother Oncol, 17 (4), 285-92
DOI 10.1016/0167-8140(90)90002-e, PubMed 1693003
Renal function related to different treatment modalities for malignant germ cell tumours
Br J Cancer, 62 (5), 842-6
DOI 10.1038/bjc.1990.391, PubMed 2173944
Long-term somatic side-effects and morbidity in testicular cancer patients
Br J Cancer, 61 (1), 151-5
DOI 10.1038/bjc.1990.31, PubMed 2297486
Publications 1989
Enlargement of the thymus following chemotherapy for non-seminomatous testicular cancer
Acta Radiol, 30 (3), 259-62
PubMed 2472163
Serum lactate dehydrogenase and human choriogonadotrophin in seminoma
Br J Urol, 63 (4), 408-15
DOI 10.1111/j.1464-410x.1989.tb05228.x, PubMed 2653557
Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment
Br J Urol, 64 (5), 530-4
DOI 10.1111/j.1464-410x.1989.tb05293.x, PubMed 2611626
DNA flow cytometry in sperm cells from unilaterally orchiectomized patients with testicular cancer before further treatment
Cytometry, 10 (3), 345-50
DOI 10.1002/cyto.990100315, PubMed 2714118
Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer
J Urol, 141 (3), 557-9
DOI 10.1016/s0022-5347(17)40892-5, PubMed 2918591
Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study
Br J Urol, 64 (5), 468-71
DOI 10.1111/j.1464-410x.1989.tb05278.x, PubMed 2611615
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867
Eur J Cancer Clin Oncol, 25 (2), 389-90
DOI 10.1016/0277-5379(89)90035-7, PubMed 2702991
Non-seminomatous testicular cancer clinical stage I: prediction of outcome by histopathological parameters. A multivariate analysis
Oncology, 46 (5), 297-300
DOI 10.1159/000226736, PubMed 2779945
The introduction of personal computers into clinical cancer research in Norway
Acta Oncol, 28 (4), 543-5
DOI 10.3109/02841868909092266, PubMed 2789833
Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer
Eur Urol, 16 (5), 335-9
DOI 10.1159/000471611, PubMed 2476317
Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer
Br J Urol, 63 (5), 531-4
DOI 10.1111/j.1464-410x.1989.tb05951.x, PubMed 2543475
Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer
Cancer, 64 (2), 404-8
DOI 10.1002/1097-0142(19890715)64:2<404::aid-cncr2820640211>3.0.co;2-7, PubMed 2736486
Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients
Int J Radiat Oncol Biol Phys, 16 (2), 383-8
DOI 10.1016/0360-3016(89)90334-9, PubMed 2921142
Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
Br J Urol, 64 (5), 524-9
DOI 10.1111/j.1464-410x.1989.tb05292.x, PubMed 2611625
Can we cure testicular cancer and retain fertility?
Prog Clin Biol Res, 303, 769-77
PubMed 2780672
[Testicular cancer. A challenge to the health services taking care of young males]
Tidsskr Nor Laegeforen, 109 (3), 337-40
PubMed 2916218
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer
J Urol, 142 (5), 1239-42
DOI 10.1016/s0022-5347(17)39044-4, PubMed 2478726
T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values
Int J Radiat Oncol Biol Phys, 17 (5), 923-9
DOI 10.1016/0360-3016(89)90137-5, PubMed 2808053
Penis cancer: a review by the Joint Radiotherapy Committee of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary and Radiotherapy Groups
J Surg Oncol, 40 (4), 227-31
DOI 10.1002/jso.2930400405, PubMed 2648076
Loss of 3p or 11p alleles is associated with testicular cancer tumors
Genomics, 5 (1), 134-8
DOI 10.1016/0888-7543(89)90097-9, PubMed 2767683
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study
Eur J Cancer Clin Oncol, 25 Suppl 3, S21-8
PubMed 2697575
Spontaneous regression of cerebral and pulmonary metastases in renal cell carcinoma
Scand J Urol Nephrol, 23 (2), 159-60
DOI 10.3109/00365598909180834, PubMed 2756362
Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder
Br J Urol, 64 (6), 604-7
DOI 10.1111/j.1464-410x.1989.tb05318.x, PubMed 2697452
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study
Cancer Treat Rev, 16 Suppl A, 111-3
DOI 10.1016/0305-7372(89)90030-3, PubMed 2670207
Primary treatment of carcinoma of the anus by combined radiotherapy and chemotherapy
Scand J Gastroenterol, 24 (10), 1243-7
DOI 10.3109/00365528909090794, PubMed 2513640
Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 25 (8), 1249-50
DOI 10.1016/0277-5379(89)90422-7, PubMed 2767112
Acute subjective morbidity after cisplatin-based combination chemotherapy in patients with testicular cancer: a prospective study
Radiother Oncol, 14 (1), 27-33
DOI 10.1016/0167-8140(89)90005-4, PubMed 2467328
Publications 1988
Induction chemotherapy in association with preoperative radiotherapy and cystectomy in bladder carcinoma--a preliminary report
Prog Clin Biol Res, 260, 621-3
PubMed 3362910
Computed tomography in primary non-seminomatous germ cell tumors of the mediastinum
Acta Radiol, 29 (3), 289-92
PubMed 2838064
Late recurrence of testicular cancer
J Clin Oncol, 6 (8), 1248-53
DOI 10.1200/JCO.1988.6.8.1248, PubMed 2842463
Is interferon with or without vinblastine the "treatment of choice" in metastatic renal cell carcinoma? The Norwegian Radium Hospital's experience 1983-1986
Semin Surg Oncol, 4 (3), 178-83
DOI 10.1002/ssu.2980040308, PubMed 3055161
[Application for basic financial support and special allowance by cancer patients with colostomies]
Tidsskr Nor Laegeforen, 108 (27), 2264-6
PubMed 3206433
Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer
Br J Urol, 62 (5), 449-53
DOI 10.1111/j.1464-410x.1988.tb04395.x, PubMed 2850071
Treatment of muscle-infiltrating bladder cancer: the Norwegian Radium Hospital's experience 1966-1982
Prog Clin Biol Res, 260, 525-41
PubMed 3129737
Relative bioavailability of oral low dose methotrexate. A comparison of 2 different formulations
Eur J Clin Pharmacol, 34 (5), 517-9
DOI 10.1007/BF01046713, PubMed 3203714
Testicular cancer in young Norwegians
J Surg Oncol, 39 (1), 43-63
DOI 10.1002/jso.2930390110, PubMed 3047500
Survival after palliative radiotherapy of liver metastases. A search for prognostic factors
Acta Oncol, 27 (1), 63-5
DOI 10.3109/02841868809090320, PubMed 2452647
DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material
APMIS, 96 (1), 25-9
DOI 10.1111/j.1699-0463.1988.tb05263.x, PubMed 3278720
DNA flow cytometry in metastases and a recurrency of malignant melanomas. A comparison of results from fresh and paraffin embedded material
Virchows Arch B Cell Pathol Incl Mol Pathol, 54 (5), 273-7
DOI 10.1007/BF02899223, PubMed 2895539
Computed tomography and conventional radiography in intrathoracic metastases from non-seminomatous testicular tumor
Acta Radiol, 29 (5), 547-9
PubMed 3166874
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma
J Urol, 139 (3), 542-4
DOI 10.1016/s0022-5347(17)42515-8, PubMed 2449547
Evaluation of response by CT in patients with advanced bladder cancer treated with cisplatinum/methotrexate
Prog Clin Biol Res, 260, 499-510
PubMed 3362903
Computed tomography of invasive bladder carcinoma after diagnostic transurethral resection
Acta Radiol, 29 (4), 435-9
PubMed 3408604
Cranial nerve dysfunction in metastatic cancer of the prostate
Br J Urol, 61 (5), 441-4
DOI 10.1111/j.1464-410x.1988.tb06594.x, PubMed 3395804
Paternity in young patients with testicular cancer--expectations and experience
Prog Clin Biol Res, 269, 481-91
PubMed 2839852
Publications 1987
Testicular seminoma: histological findings and their prognostic significance for stage II disease
J Surg Oncol, 36 (3), 166-9
DOI 10.1002/jso.2930360304, PubMed 3682835
[Radiotherapy and chemotherapy in anal carcinoma]
Tidsskr Nor Laegeforen, 107 (1), 50-2, 61
PubMed 3103254
Improved subjective tolerability of interferon by combination with prednisolone
Eur J Cancer Clin Oncol, 23 (6), 875-6
DOI 10.1016/0277-5379(87)90295-1, PubMed 3653205
To meet spiritual needs of the cancer patient--a responsibility for the oncologist?
Acta Oncol, 26 (1), 75-6
DOI 10.3109/02841868709092982, PubMed 2439109
Palliative pelvic radiotherapy in patients with hormone-resistant prostatic cancer
Prog Clin Biol Res, 243B, 479-85
PubMed 2443925
The treatment of advanced metastatic seminoma: experience in 55 cases
J Clin Oncol, 5 (7), 1071-7
DOI 10.1200/JCO.1987.5.7.1071, PubMed 2439660
Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: a progress report
Int J Cancer Suppl, 1, 36-40
DOI 10.1002/ijc.2910390708, PubMed 3476476
Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study
Scand J Urol Nephrol, 21 (1), 39-42
DOI 10.3109/00365598709180288, PubMed 3589522
Cancer of the penis. Experience at the Norwegian Radium Hospital 1974-1985
Eur Urol, 13 (6), 372-7
PubMed 3428320
Life with an ileal conduit in cystectomized bladder cancer patients: expectations and experience
Scand J Urol Nephrol, 21 (2), 97-101
DOI 10.3109/00365598709180301, PubMed 3616512
Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate
Scand J Urol Nephrol, 21 (1), 13-6
DOI 10.3109/00365598709180283, PubMed